Inhibition	O
of	O
AP-1	B-protein
by	O
the	O
glucocorticoid-inducible	O
protein	B-protein
GILZ	I-protein
.	O

The	O
immunosuppressive	O
effects	O
of	O
glucocorticoids	O
arise	O
largely	O
by	O
inhibition	O
of	O
cytokine	O
gene	O
expression	O
,	O
which	O
has	O
been	O
ascribed	O
to	O
interference	O
between	O
the	O
glucocorticoid	B-protein
receptor	I-protein
and	O
transcription	B-protein
factors	I-protein
such	O
as	O
AP-1	B-protein
and	O
NF-kappa	B-protein
B	I-protein
as	O
well	O
as	O
by	O
competition	O
for	O
common	O
coactivators	O
.	O

Here	O
we	O
show	O
that	O
glucocorticoid-induced	O
inhibition	O
of	O
interleukin-2	O
mRNA	O
expression	O
in	O
activated	B-cell_type
normal	I-cell_type
T	I-cell_type
cells	I-cell_type
required	O
new	O
protein	O
synthesis	O
,	O
suggesting	O
that	O
this	O
phenomenon	O
is	O
secondary	O
to	O
expression	O
of	O
glucocorticoid-regulated	O
genes	B-DNA
.	O

One	O
of	O
the	O
most	O
prominent	O
glucocorticoid-induced	O
genes	B-DNA
is	O
glucocorticoid-induced	B-DNA
leucine	I-DNA
zipper	I-DNA
(	O
GILZ	B-DNA
)	O
,	O
which	O
has	O
been	O
reported	O
to	O
inhibit	O
activation-induced	O
up-regulation	O
of	O
Fas	B-RNA
ligand	I-RNA
(	I-RNA
FasL	I-RNA
)	I-RNA
mRNA	I-RNA
.	O

Indeed	O
,	O
transient	O
expression	O
of	O
GILZ	B-DNA
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
blocked	O
induction	O
of	O
a	O
reporter	B-DNA
construct	I-DNA
driven	O
by	O
the	O
FasL	B-DNA
promoter	I-DNA
.	O

This	O
could	O
be	O
accounted	O
for	O
by	O
GILZ	B-protein
-mediated	O
inhibition	O
of	O
Egr-2	B-protein
and	O
Egr-3	B-protein
,	O
NFAT/AP-1	B-protein
-inducible	O
transcription	B-protein
factors	I-protein
that	O
bind	O
a	O
regulatory	B-DNA
element	I-DNA
in	O
the	O
FasL	B-DNA
promoter	I-DNA
and	O
up-regulate	O
FasL	O
expression	O
.	O

GILZ	B-protein
also	O
potently	O
inhibited	O
AP-1-driven	B-DNA
and	I-DNA
IL-2	I-DNA
promoter-driven	I-DNA
reporter	I-DNA
constructs	I-DNA
,	O
and	O
recombinant	O
GILZ	B-protein
specifically	O
interacted	O
with	O
c-Fos	B-protein
and	O
c-Jun	B-protein
in	O
vitro	O
and	O
inhibited	O
the	O
binding	O
of	O
active	B-protein
AP-1	I-protein
to	O
its	O
target	O
DNA	O
.	O

Whereas	O
homodimerization	O
of	O
GILZ	B-protein
required	O
the	O
presence	O
of	O
its	O
leucine	B-protein
zipper	I-protein
,	O
the	O
interaction	O
with	O
c-Fos	B-protein
and	O
c-Jun	B-protein
occurred	O
through	O
the	O
N-terminal	B-protein
60-amino	B-protein
acid	I-protein
region	I-protein
of	O
GILZ	B-protein
.	O

Thus	O
,	O
GILZ	B-protein
represents	O
a	O
glucocorticoid-induced	O
gene	O
product	O
that	O
can	O
inhibit	O
a	O
variety	O
of	O
activation-induced	O
events	O
,	O
at	O
least	O
in	O
part	O
by	O
direct	O
interference	O
with	O
AP-1	B-protein
,	O
and	O
is	O
therefore	O
a	O
candidate	O
for	O
a	O
mediator	O
of	O
glucocorticoid-induced	O
immunosuppression	O
.	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
Vol	NULL
.	NULL

276	NULL
,	NULL
No	NULL
.	NULL

31	NULL
,	NULL
Issue	NULL
of	NULL
August	NULL
3	NULL
,	NULL
pp	NULL
.	NULL

29603-29610	NULL
,	NULL
2001	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Inhibition	NULL
of	NULL
AP-1	NULL
by	NULL
the	NULL
Glucocorticoid-inducible	NULL
Protein	NULL
GILZ*	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
February	NULL
19	NULL
,	NULL
2001	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
June	NULL
6	NULL
,	NULL
2001	NULL
Published	NULL
,	NULL
JBC	NULL
Papers	NULL
in	NULL
Press	NULL
,	NULL
June	NULL
7	NULL
,	NULL
2001	NULL
,	NULL
DOI	NULL
10.1074/jbc.M101522200	NULL
Paul	NULL
R.	NULL
Mittelstadt	NULL
and	NULL
Jonathan	NULL
D.	NULL
Ashwell	NULL
$	NULL
From	NULL
the	NULL
Laboratory	NULL
of	NULL
Immune	NULL
Cell	NULL
Biology	NULL
,	NULL
NCI	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892	NULL
The	NULL
immunosuppressive	NULL
effects	NULL
of	NULL
glucocorticoids	NULL
arise	NULL
largely	NULL
by	NULL
inhibition	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
,	NULL
which	NULL
has	NULL
been	NULL
ascribed	NULL
to	NULL
interference	NULL
between	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
and	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
AP-1	NULL
and	NULL
NF	NULL
-B	NULL
as	NULL
well	NULL
as	NULL
by	NULL
competition	NULL
for	NULL
common	NULL
coactivators	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
glucocorticoid-induced	NULL
inhibition	NULL
of	NULL
interleukin-2	NULL
mRNA	NULL
expression	NULL
in	NULL
activated	NULL
normal	NULL
T	NULL
cells	NULL
required	NULL
new	NULL
protein	NULL
synthesis	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
phenomenon	NULL
is	NULL
secondary	NULL
to	NULL
expression	NULL
of	NULL
glucocorti-coid-regulated	NULL
genes	NULL
.	NULL

One	NULL
of	NULL
the	NULL
most	NULL
prominent	NULL
glucocorticoid-induced	NULL
genes	NULL
is	NULL
glucocorticoid-induced	NULL
leucine	NULL
zipper	NULL
(	NULL
GILZ	NULL
)	NULL
,	NULL
which	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
inhibit	NULL
activation-induced	NULL
up-regulation	NULL
of	NULL
Fas	NULL
ligand	NULL
(	NULL
FasL	NULL
)	NULL
mRNA	NULL
.	NULL

Indeed	NULL
,	NULL
transient	NULL
expression	NULL
of	NULL
GILZ	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
blocked	NULL
induction	NULL
of	NULL
a	NULL
reporter	NULL
construct	NULL
driven	NULL
by	NULL
the	NULL
FasL	NULL
promoter	NULL
.	NULL

This	NULL
could	NULL
be	NULL
accounted	NULL
for	NULL
by	NULL
GILZ-mediated	NULL
inhibition	NULL
of	NULL
Egr-2	NULL
and	NULL
Egr-3	NULL
,	NULL
NFAT/AP-1-inducible	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
a	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
FasL	NULL
promoter	NULL
and	NULL
up-regulate	NULL
FasL	NULL
ex-pression	NULL
.	NULL

GILZ	NULL
also	NULL
potently	NULL
inhibited	NULL
AP-l-driven	NULL
and	NULL
IL-2	NULL
promoter-driven	NULL
reporter	NULL
constructs	NULL
,	NULL
and	NULL
recombi-nant	NULL
GILZ	NULL
specifically	NULL
interacted	NULL
with	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
in	NULL
vitro	NULL
and	NULL
inhibited	NULL
the	NULL
binding	NULL
of	NULL
active	NULL
AP-1	NULL
to	NULL
its	NULL
target	NULL
DNA	NULL
.	NULL

Whereas	NULL
homodimerization	NULL
of	NULL
GILZ	NULL
required	NULL
the	NULL
presence	NULL
of	NULL
its	NULL
leucine	NULL
zipper	NULL
,	NULL
the	NULL
interaction	NULL
with	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
occurred	NULL
through	NULL
the	NULL
N-terminal	NULL
60-amino	NULL
acid	NULL
region	NULL
of	NULL
GILZ	NULL
.	NULL

Thus	NULL
,	NULL
GILZ	NULL
represents	NULL
a	NULL
glucocorticoid-induced	NULL
gene	NULL
product	NULL
that	NULL
can	NULL
inhibit	NULL
a	NULL
variety	NULL
of	NULL
activation-induced	NULL
events	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
by	NULL
direct	NULL
interference	NULL
with	NULL
AP-1	NULL
,	NULL
and	NULL
is	NULL
therefore	NULL
a	NULL
candidate	NULL
for	NULL
a	NULL
mediator	NULL
of	NULL
glucocorticoid-induced	NULL
immunosuppression	NULL
.	NULL

Glucocorticoids	NULL
are	NULL
potent	NULL
immunosuppressive	NULL
agents	NULL
that	NULL
inhibit	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
cytokine	NULL
production	NULL
.	NULL

They	NULL
are	NULL
used	NULL
clinically	NULL
for	NULL
treatment	NULL
of	NULL
autoimmune	NULL
and	NULL
inflammatory	NULL
dis-eases	NULL
,	NULL
such	NULL
as	NULL
rheumatoid	NULL
arthritis	NULL
and	NULL
asthma	NULL
,	NULL
and	NULL
for	NULL
preventing	NULL
transplant	NULL
rejection	NULL
.	NULL

Glucocorticoids	NULL
inhibit	NULL
transcriptional	NULL
up-regulation	NULL
of	NULL
T	NULL
cell-derived	NULL
cytokines	NULL
,	NULL
such	NULL
as	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-10	NULL
,	NULL
and	NULL
y-interferon	NULL
(	NULL
1-3	NULL
)	NULL
,	NULL
and	NULL
proinflammatory	NULL
cytokines	NULL
,	NULL
such	NULL
as	NULL
IL-1	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stim-ulating	NULL
factor	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
.	NULL

Another	NULL
target	NULL
of	NULL
*	NULL
The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

J	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Rm	NULL
.	NULL

1B-40	NULL
,	NULL
Bdg	NULL
.	NULL

10	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
801-496-4981	NULL
;	NULL
Fax	NULL
:	NULL
301-402-4844	NULL
;	NULL
E-mail	NULL
:	NULL
jda	NULL
@	NULL
pop.nci.nih.gov	NULL
.	NULL
'	NULL

The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
GR	NULL
,	NULL
glucocorticoid	NULL
re-ceptor	NULL
;	NULL
GRE	NULL
,	NULL
glucocorticoid-responsive	NULL
element	NULL
;	NULL
TRE	NULL
,	NULL
TPA-responsive	NULL
element	NULL
;	NULL
GST	NULL
,	NULL
glutathione	NULL
S-transferase	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
myristate	NULL
ace-tate	NULL
;	NULL
GAPDH	NULL
,	NULL
glyceraldyhyde-3-phosphate	NULL
dehydrogenase	NULL
;	NULL
MOPS	NULL
,	NULL
3-morpholinopropanesulfonic	NULL
acid	NULL
;	NULL
CHX	NULL
,	NULL
cycloheximide	NULL
;	NULL
Dex	NULL
,	NULL
dexam-ethasone	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
;	NULL
TCR	NULL
,	NULL
T	NULL
cell	NULL
recep-tor	NULL
;	NULL
Tet	NULL
,	NULL
tetracycline	NULL
;	NULL
Dox	NULL
,	NULL
doxycycline	NULL
;	NULL
GILZ	NULL
,	NULL
glucocorticoid-induced	NULL
leucine	NULL
zipper	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
glucocorticoids	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
Fas	NULL
ligand	NULL
(	NULL
FasL	NULL
)	NULL
,	NULL
a	NULL
membrane	NULL
protein	NULL
that	NULL
triggers	NULL
apoptosis	NULL
of	NULL
mature	NULL
T	NULL
cells	NULL
by	NULL
engaging	NULL
Fas	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
FasL-initiated	NULL
apoptosis	NULL
by	NULL
glucocorticoids	NULL
may	NULL
help	NULL
to	NULL
stem	NULL
the	NULL
loss	NULL
of	NULL
immune	NULL
cells	NULL
in	NULL
HIV-infected	NULL
individuals	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
apparent	NULL
immune-enhancing	NULL
effect	NULL
of	NULL
FasL	NULL
suppression	NULL
underscores	NULL
the	NULL
complexity	NULL
of	NULL
glucocorticoid	NULL
biology	NULL
and	NULL
implies	NULL
that	NULL
there	NULL
are	NULL
numerous	NULL
levels	NULL
where	NULL
glucocorticoid	NULL
actions	NULL
are	NULL
controlled	NULL
.	NULL

Glucocorticoids	NULL
are	NULL
small	NULL
hydrophobic	NULL
molecules	NULL
that	NULL
diffuse	NULL
through	NULL
the	NULL
plasma	NULL
membrane	NULL
to	NULL
reach	NULL
the	NULL
cytosolic	NULL
glucocorticoid	NULL
receptor	NULL
(	NULL
GR	NULL
)	NULL
,	NULL
which	NULL
then	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
to	NULL
regulate	NULL
transcription	NULL
.	NULL

The	NULL
GR	NULL
contains	NULL
an	NULL
N-terminal	NULL
hor-mone-independent	NULL
activation	NULL
domain	NULL
,	NULL
a	NULL
DNA-binding	NULL
domain	NULL
containing	NULL
a	NULL
pair	NULL
of	NULL
zinc	NULL
fingers	NULL
,	NULL
and	NULL
a	NULL
C-terminal	NULL
ligand-de-pendent	NULL
activation	NULL
domain	NULL
integrated	NULL
with	NULL
the	NULL
ligand-binding	NULL
domain	NULL
(	NULL
2	NULL
,	NULL
7	NULL
)	NULL
.	NULL

The	NULL
C	NULL
terminus	NULL
is	NULL
also	NULL
the	NULL
site	NULL
of	NULL
interaction	NULL
with	NULL
coactivator	NULL
proteins	NULL
,	NULL
including	NULL
SRC-1	NULL
,	NULL
CBP/p300	NULL
,	NULL
and	NULL
PCAF	NULL
(	NULL
8-10	NULL
)	NULL
.	NULL

Ligand-bound	NULL
GR	NULL
is	NULL
mostly	NULL
monomeric	NULL
in	NULL
solution	NULL
but	NULL
homodimerizes	NULL
upon	NULL
cooperative	NULL
binding	NULL
to	NULL
a	NULL
GRE	NULL
,	NULL
a	NULL
region	NULL
of	NULL
DNA	NULL
containing	NULL
two	NULL
inversely	NULL
symmetrical	NULL
GR-binding	NULL
elements	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Classic	NULL
GREs	NULL
regulate	NULL
glucocorticoid-inducible	NULL
genes	NULL
that	NULL
play	NULL
roles	NULL
in	NULL
metabolism	NULL
and	NULL
cell	NULL
growth	NULL
,	NULL
such	NULL
as	NULL
those	NULL
encoding	NULL
metallothionein	NULL
,	NULL
tyrosine	NULL
aminotransferase	NULL
,	NULL
al-anine	NULL
aminotransferase	NULL
,	NULL
and	NULL
phosphoenolpyruvate	NULL
carboxyki-nase	NULL
(	NULL
7	NULL
,	NULL
12	NULL
)	NULL
.	NULL

The	NULL
activated	NULL
GR	NULL
can	NULL
also	NULL
suppress	NULL
transcription	NULL
upon	NULL
binding	NULL
negative	NULL
GREs	NULL
,	NULL
whose	NULL
sequences	NULL
differ	NULL
from	NULL
the	NULL
classic	NULL
GRE	NULL
,	NULL
and	NULL
are	NULL
found	NULL
in	NULL
the	NULL
genes	NULL
encoding	NULL
IL-1§	NULL
(	NULL
13	NULL
)	NULL
,	NULL
pro-opiomelanocortin	NULL
(	NULL
14	NULL
)	NULL
,	NULL
prolactin	NULL
(	NULL
15	NULL
)	NULL
,	NULL
«	NULL
-subunit	NULL
of	NULL
glycopro-tein	NULL
hormone	NULL
(	NULL
16	NULL
)	NULL
,	NULL
and	NULL
proliferin	NULL
(	NULL
17	NULL
)	NULL
.	NULL

GREs	NULL
adjacent	NULL
to	NULL
other	NULL
transcription	NULL
factor-binding	NULL
sites	NULL
,	NULL
such	NULL
as	NULL
for	NULL
AP-1	NULL
,	NULL
can	NULL
contribute	NULL
to	NULL
the	NULL
function	NULL
of	NULL
composite	NULL
elements	NULL
where	NULL
the	NULL
GR	NULL
can	NULL
have	NULL
either	NULL
positive	NULL
or	NULL
negative	NULL
effects	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
cellular	NULL
context	NULL
and	NULL
the	NULL
composition	NULL
of	NULL
AP-1	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Increasing	NULL
evidence	NULL
indicates	NULL
that	NULL
the	NULL
GR	NULL
also	NULL
represses	NULL
gene	NULL
activation	NULL
without	NULL
binding	NULL
DNA	NULL
.	NULL

This	NULL
mode	NULL
of	NULL
repression	NULL
,	NULL
termed	NULL
``	NULL
direct	NULL
interference	NULL
``	NULL
(	NULL
19	NULL
)	NULL
,	NULL
has	NULL
been	NULL
associated	NULL
with	NULL
glucocorticoid	NULL
inhibition	NULL
of	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
transcription	NULL
factors	NULL
that	NULL
contribute	NULL
to	NULL
the	NULL
transcriptional	NULL
induction	NULL
of	NULL
most	NULL
cytokine	NULL
genes	NULL
.	NULL

The	NULL
first	NULL
reported	NULL
example	NULL
of	NULL
direct	NULL
interference	NULL
was	NULL
glucocorticoid	NULL
repression	NULL
of	NULL
the	NULL
AP-1	NULL
response	NULL
element	NULL
(	NULL
TRE	NULL
)	NULL
of	NULL
the	NULL
collagenase	NULL
gene	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Both	NULL
components	NULL
of	NULL
AP-1	NULL
,	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
,	NULL
were	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
GR	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
GR	NULL
to	NULL
DNA	NULL
interaction	NULL
.	NULL

Levels	NULL
of	NULL
AP-1	NULL
in	NULL
the	NULL
nucleus	NULL
were	NULL
not	NULL
altered	NULL
by	NULL
glucocorticoids	NULL
,	NULL
and	NULL
the	NULL
ability	NULL
of	NULL
AP-1	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
TRE	NULL
was	NULL
unaffected	NULL
(	NULL
20	NULL
,	NULL
22	NULL
)	NULL
.	NULL

When	NULL
over-expressed	NULL
,	NULL
however	NULL
,	NULL
the	NULL
GR	NULL
could	NULL
displace	NULL
c-Jun	NULL
from	NULL
the	NULL
TRE	NULL
(	NULL
21	NULL
)	NULL
,	NULL
and	NULL
c-Jun	NULL
could	NULL
displace	NULL
the	NULL
GR	NULL
from	NULL
the	NULL
GRE	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
notion	NULL
that	NULL
the	NULL
liganded	NULL
GR	NULL
was	NULL
directly	NULL
interfering	NULL
with	NULL
AP-1	NULL
function	NULL
were	NULL
the	NULL
observations	NULL
that	NULL
repression	NULL
could	NULL
take	NULL
place	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
new	NULL
protein	NULL
synthesis	NULL
,	NULL
occurred	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
the	NULL
synthetic	NULL
glucocorticoid	NULL
dexamethasone	NULL
(	NULL
Dex	NULL
)	NULL
lower	NULL
than	NULL
that	NULL
required	NULL
for	NULL
transcriptional	NULL
induction	NULL
by	NULL
the	NULL
GR	NULL
(	NULL
20	NULL
)	NULL
,	NULL
and	NULL
could	NULL
be	NULL
carried	NULL
out	NULL
by	NULL
mutant	NULL
GRs	NULL
whose	NULL
transactivation	NULL
ability	NULL
was	NULL
disrupted	NULL
(	NULL
20	NULL
,	NULL
296083	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
29604	NULL
CHX	NULL
-	NULL
--	NULL
-+	NULL
Dex	NULL
_-	NULL
=-	NULL
°	NULL
+	NULL
#	NULL
o-	NULL
o-	NULL
°	NULL
o+	NULL
°	NULL
o+	NULL
P+I	NULL
--	NULL
#	NULL
-	NULL
°	NULL
o+	NULL
o-	NULL
+	NULL
-o	NULL
+	NULL
ce	NULL
~	NULL
w	NULL
0	NULL
Wb	NULL
w	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Repression	NULL
of	NULL
IL-2	NULL
mRNA	NULL
induction	NULL
by	NULL
Dex	NULL
requires	NULL
new	NULL
protein	NULL
synthesis	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
1	NULL
uM	NULL
Dex	NULL
and	NULL
20	NULL
nM	NULL
CHX	NULL
.	NULL

After	NULL
3	NULL
h	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
,	NULL
and	NULL
IL-2	NULL
mRNA	NULL
was	NULL
assessed	NULL
by	NULL
Northern	NULL
blotting	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Equivalence	NULL
of	NULL
loading	NULL
among	NULL
all	NULL
samples	NULL
was	NULL
verified	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
of	NULL
the	NULL
gel	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Equivalence	NULL
of	NULL
loading	NULL
among	NULL
CHX-treated	NULL
and	NULL
-untreated	NULL
groups	NULL
of	NULL
samples	NULL
was	NULL
determined	NULL
by	NULL
re-probing	NULL
the	NULL
membrane	NULL
with	NULL
GAPDH	NULL
cDNA	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
experiment	NULL
shown	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

P	NULL
+	NULL
I	NULL
,	NULL
PMA	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
+	NULL
ionomycin	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
.	NULL

memes	NULL
-	NULL
Wp	NULL
21	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Direct	NULL
interference	NULL
by	NULL
the	NULL
GR	NULL
with	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-kB	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
direct	NULL
interference	NULL
model	NULL
for	NULL
repression	NULL
by	NULL
nuclear	NULL
receptors	NULL
has	NULL
been	NULL
extended	NULL
to	NULL
the	NULL
octamer-binding	NULL
factors	NULL
(	NULL
25	NULL
)	NULL
and	NULL
C/EBP	NULL
(	NULL
26	NULL
)	NULL
(	NULL
repressed	NULL
by	NULL
the	NULL
estrogen	NULL
receptor	NULL
)	NULL
.	NULL

The	NULL
direct	NULL
interference	NULL
model	NULL
was	NULL
further	NULL
supported	NULL
through	NULL
the	NULL
use	NULL
of	NULL
a	NULL
C-terminal	NULL
zinc	NULL
finger	NULL
point	NULL
mutant	NULL
GR	NULL
whose	NULL
homo-dimerization	NULL
surface	NULL
was	NULL
dis-rupted	NULL
,	NULL
preventing	NULL
cooperative	NULL
binding	NULL
to	NULL
and	NULL
transactivation	NULL
through	NULL
the	NULL
classic	NULL
GRE	NULL
,	NULL
which	NULL
was	NULL
able	NULL
to	NULL
repress	NULL
AP-1	NULL
activity	NULL
as	NULL
a	NULL
monomer	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Mice	NULL
whose	NULL
normal	NULL
GR	NULL
was	NULL
replaced	NULL
by	NULL
this	NULL
mutant	NULL
appeared	NULL
grossly	NULL
normal	NULL
and	NULL
had	NULL
no	NULL
obvious	NULL
peripheral	NULL
lymphoid	NULL
defects	NULL
,	NULL
although	NULL
their	NULL
thymocytes	NULL
did	NULL
not	NULL
undergo	NULL
apoptosis	NULL
upon	NULL
treatment	NULL
with	NULL
Dex	NULL
in	NULL
vitro	NULL
(	NULL
28	NULL
)	NULL
.	NULL

In	NULL
embryonic	NULL
fibroblasts	NULL
from	NULL
these	NULL
mice	NULL
,	NULL
Dex	NULL
could	NULL
block	NULL
the	NULL
TRE	NULL
and	NULL
the	NULL
inflammatory	NULL
mediators	NULL
collagenase	NULL
and	NULL
gelatin-ase	NULL
B	NULL
,	NULL
suggesting	NULL
that	NULL
direct	NULL
interference	NULL
is	NULL
a	NULL
major	NULL
,	NULL
if	NULL
not	NULL
the	NULL
predominant	NULL
,	NULL
physiological	NULL
mode	NULL
of	NULL
action	NULL
of	NULL
the	NULL
GR	NULL
.	NULL

Another	NULL
transcription-independent	NULL
model	NULL
for	NULL
repression	NULL
by	NULL
the	NULL
GR	NULL
invokes	NULL
competition	NULL
,	NULL
or	NULL
``	NULL
squelching	NULL
,	NULL
``	NULL
between	NULL
the	NULL
GR	NULL
and	NULL
AP-1	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
for	NULL
mutual	NULL
coactivators	NULL
such	NULL
as	NULL
p300/CBP	NULL
.	NULL

These	NULL
coactivators	NULL
possess	NULL
histone	NULL
acetyltransferase	NULL
activity	NULL
,	NULL
which	NULL
acts	NULL
on	NULL
chromatin	NULL
to	NULL
permit	NULL
access	NULL
to	NULL
site-specific	NULL
transcription	NULL
factors	NULL
.	NULL

Limiting	NULL
coactivators	NULL
would	NULL
thus	NULL
serve	NULL
to	NULL
direct	NULL
the	NULL
cellular	NULL
response	NULL
toward	NULL
the	NULL
strongest	NULL
signal	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Evidence	NULL
supporting	NULL
this	NULL
model	NULL
is	NULL
based	NULL
on	NULL
studies	NULL
in	NULL
which	NULL
overexpression	NULL
of	NULL
coactivators	NULL
(	NULL
30	NULL
)	NULL
or	NULL
treatment	NULL
with	NULL
histone	NULL
de-acetylase	NULL
inhibitors	NULL
relieves	NULL
glucocorticoid	NULL
repression	NULL
(	NULL
31	NULL
)	NULL
.	NULL

However	NULL
,	NULL
this	NULL
model	NULL
does	NULL
not	NULL
satisfactorily	NULL
account	NULL
,	NULL
for	NULL
example	NULL
,	NULL
for	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
activated	NULL
retinoic	NULL
acid	NULL
receptor	NULL
to	NULL
repress	NULL
AP-1	NULL
but	NULL
not	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
additional	NULL
mechanisms	NULL
would	NULL
be	NULL
needed	NULL
to	NULL
confer	NULL
specificity	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
immunosuppressive	NULL
effects	NULL
of	NULL
glucocorticoids	NULL
might	NULL
be	NULL
due	NULL
at	NULL
least	NULL
in	NULL
part	NULL
to	NULL
mechanisms	NULL
other	NULL
than	NULL
direct	NULL
interference	NULL
or	NULL
squelching	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
the	NULL
glucocorticoid-mediated	NULL
inhibition	NULL
of	NULL
activation-induced	NULL
up-regulation	NULL
of	NULL
IL-2	NULL
mRNA	NULL
requires	NULL
new	NULL
protein	NULL
synthesis	NULL
.	NULL

Cycloheximide	NULL
prevented	NULL
the	NULL
suppression	NULL
,	NULL
suggesting	NULL
that	NULL
a	NULL
glucocorticoid-induced	NULL
gene	NULL
product	NULL
might	NULL
be	NULL
responsible	NULL
.	NULL

A	NULL
recent	NULL
analysis	NULL
of	NULL
glucocorticoid-inducible	NULL
genes	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
by	NULL
cDNA	NULL
gene	NULL
chip	NULL
array	NULL
found	NULL
that	NULL
among	NULL
the	NULL
over	NULL
9,000	NULL
cDNA	NULL
tested	NULL
,	NULL
the	NULL
most	NULL
highly	NULL
induced	NULL
gene	NULL
was	NULL
the	NULL
DSIPI	NULL
(	NULL
``	NULL
delta	NULL
sleep-inducing	NULL
peptide	NULL
immunoreactor	NULL
,	NULL
``	NULL
named	NULL
for	NULL
its	NULL
shared	NULL
immunoreac-tivity	NULL
with	NULL
the	NULL
sequence-unrelated	NULL
nonamer	NULL
neuropeptide	NULL
Inhibition	NULL
of	NULL
AP-1	NULL
by	NULL
GILZ	NULL
DSIP	NULL
(	NULL
33	NULL
)	NULL
)	NULL
.2	NULL
DSIPI	NULL
shares	NULL
nearly	NULL
100	NULL
%	NULL
nucleotide	NULL
sequence	NULL
homology	NULL
with	NULL
the	NULL
C-terminal	NULL
75	NULL
%	NULL
of	NULL
human	NULL
glucocorticoid-induced	NULL
leucine	NULL
zipper	NULL
(	NULL
GILZ	NULL
)	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Because	NULL
murine	NULL
GILZ	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
inhibit	NULL
the	NULL
expression	NULL
of	NULL
FasL	NULL
in	NULL
activated	NULL
T	NULL
hybridoma	NULL
cells	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
possibility	NULL
that	NULL
this	NULL
glucocorticoid-responsive	NULL
gene	NULL
might	NULL
mediate	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
glucocorticoids	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
activation-induced	NULL
genes	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cells	NULL
,	NULL
Reagents	NULL
,	NULL
and	NULL
Antibodies-The	NULL
Jurkat	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
(	NULL
ATCC	NULL
)	NULL
and	NULL
the	NULL
murine	NULL
T	NULL
cell	NULL
hybridoma	NULL
MA	NULL
5.8	NULL
(	NULL
85	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
Biofluids	NULL
Inc.	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
supplemented	NULL
with	NULL
4	NULL
mM	NULL
glutamine	NULL
,	NULL
50	NULL
uM	NULL
B-mercaptoethanol	NULL
,	NULL
100	NULL
units/ml	NULL
penicillin	NULL
,	NULL
150	NULL
ug/ml	NULL
gentamicin	NULL
,	NULL
and	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
NIH	NULL
Blood	NULL
Bank	NULL
and	NULL
were	NULL
isolated	NULL
by	NULL
density	NULL
gradient	NULL
centrifugation	NULL
with	NULL
the	NULL
use	NULL
of	NULL
lymphocyte	NULL
separation	NULL
medium	NULL
(	NULL
Biofluids	NULL
)	NULL
.	NULL

Antisera	NULL
against	NULL
GILZ	NULL
were	NULL
prepared	NULL
by	NULL
immunizing	NULL
with	NULL
the	NULL
GST-GILZ	NULL
fusion	NULL
protein	NULL
.	NULL

A	NULL
rabbit	NULL
was	NULL
immunized	NULL
with	NULL
500	NULL
ug	NULL
of	NULL
the	NULL
GST-GILZ	NULL
fusion	NULL
protein	NULL
mixed	NULL
with	NULL
complete	NULL
Freund	NULL
's	NULL
adjuvant	NULL
and	NULL
was	NULL
boosted	NULL
with	NULL
100	NULL
ug	NULL
of	NULL
GST-GILZ	NULL
in	NULL
incomplete	NULL
Freund	NULL
's	NULL
adjuvant	NULL
at	NULL
2-4-week	NULL
intervals	NULL
.	NULL

The	NULL
monoclonal	NULL
antibody	NULL
against	NULL
TCR-¢	NULL
was	NULL
obtained	NULL
from	NULL
Ralph	NULL
Kubo	NULL
(	NULL
La	NULL
Jolla	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Immunology	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
(	NULL
86	NULL
)	NULL
.	NULL

PMA	NULL
,	NULL
ionomycin	NULL
,	NULL
dexamethasone	NULL
,	NULL
and	NULL
doxycycline	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
.	NULL

Plasmids-Luciferase	NULL
reporters	NULL
containing	NULL
511	NULL
nucleotides	NULL
upstream	NULL
of	NULL
the	NULL
FasL	NULL
translation	NULL
initiation	NULL
site	NULL
(	NULL
-511	NULL
)	NULL
or	NULL
containing	NULL
the	NULL
Egr-binding	NULL
site	NULL
(	NULL
FLRE	NULL
)	NULL
(	NULL
87	NULL
)	NULL
and	NULL
Egr-2-	NULL
(	NULL
88	NULL
)	NULL
and	NULL
Eigr-3-driven	NULL
(	NULL
89	NULL
)	NULL
luciferase	NULL
reporters	NULL
have	NULL
been	NULL
described	NULL
.	NULL

The	NULL
eukaryotic	NULL
expression	NULL
plasmid	NULL
TAM-67	NULL
,	NULL
encoding	NULL
a	NULL
transactivation-defective	NULL
c-Jun	NULL
mutant	NULL
,	NULL
and	NULL
the	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
TRE-lue	NULL
,	NULL
driven	NULL
by	NULL
six	NULL
copies	NULL
of	NULL
the	NULL
proximal	NULL
(	NULL
-153	NULL
)	NULL
TRE	NULL
element	NULL
from	NULL
the	NULL
murine	NULL
IL-2	NULL
promoter	NULL
,	NULL
NFAT-luc	NULL
,	NULL
driven	NULL
by	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
distal	NULL
(	NULL
-287	NULL
)	NULL
NFAT/AP-1	NULL
element	NULL
of	NULL
the	NULL
murine	NULL
IL-2	NULL
promoter	NULL
,	NULL
and	NULL
IL-2-luc	NULL
,	NULL
driven	NULL
by	NULL
0.3	NULL
kilobase	NULL
pairs	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
,	NULL
have	NULL
been	NULL
described	NULL
(	NULL
40	NULL
)	NULL
.	NULL

c-fos	NULL
and	NULL
c-jun	NULL
in	NULL
pcDNA	NULL
expression	NULL
vectors	NULL
were	NULL
obtained	NULL
from	NULL
Nancy	NULL
Colburn	NULL
(	NULL
NCI	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
)	NULL
.	NULL

The	NULL
GILZ	NULL
cDNA	NULL
was	NULL
amplified	NULL
from	NULL
total	NULL
RNA	NULL
obtained	NULL
from	NULL
Dex-treated	NULL
murine	NULL
2B4.11	NULL
hybridoma	NULL
cells	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Nucleotide	NULL
65	NULL
of	NULL
GILZ	NULL
derived	NULL
from	NULL
2B4.11	NULL
cells	NULL
(	NULL
T	NULL
)	NULL
differed	NULL
from	NULL
the	NULL
corresponding	NULL
nucleotide	NULL
in	NULL
the	NULL
original	NULL
characterization	NULL
of	NULL
this	NULL
gene	NULL
(	NULL
C	NULL
)	NULL
(	NULL
GenBank	NULL
NM	NULL
010286	NULL
)	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
change	NULL
in	NULL
the	NULL
predicted	NULL
amino	NULL
acid	NULL
sequence	NULL
from	NULL
a	NULL
threonine	NULL
to	NULL
an	NULL
isoleucine	NULL
.	NULL

This	NULL
difference	NULL
was	NULL
also	NULL
found	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
hybridoma	NULL
3DO	NULL
,	NULL
as	NULL
well	NULL
as	NULL
spleen	NULL
cells	NULL
from	NULL
C57/BL6	NULL
mice	NULL
,	NULL
and	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
published	NULL
nucleotide	NULL
sequences	NULL
of	NULL
rat	NULL
(	NULL
ABO254831	NULL
)	NULL
and	NULL
human	NULL
(	NULL
ABO254832	NULL
)	NULL
GILZ	NULL
.	NULL

After	NULL
adding	NULL
a	NULL
C-terminal	NULL
Myc	NULL
tag	NULL
epitope	NULL
,	NULL
the	NULL
cDNA	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
EcoRI	NULL
and	NULL
Xbal	NULL
sites	NULL
of	NULL
the	NULL
expression	NULL
vector	NULL
pCI-neo	NULL
(	NULL
Promega	NULL
,	NULL
Mad-ison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

The	NULL
GILZ	NULL
mutant	NULL
ALZ	NULL
,	NULL
from	NULL
which	NULL
leucine	NULL
zipper-spanning	NULL
amino	NULL
acids	NULL
76-96	NULL
were	NULL
removed	NULL
,	NULL
was	NULL
generated	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
and	NULL
subcloned	NULL
into	NULL
pCI-neo	NULL
.	NULL

GILZ-	NULL
(	NULL
C-terminal	NULL
)	NULL
Mye	NULL
was	NULL
transferred	NULL
into	NULL
the	NULL
tetracycline-regulated	NULL
expression	NULL
vector	NULL
peDNA4/TO	NULL
(	NULL
Invitrogen	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
peDNA6	NULL
,	NULL
encoding	NULL
the	NULL
tetracycline	NULL
repressor	NULL
,	NULL
was	NULL
obtained	NULL
from	NULL
Invitrogen	NULL
.	NULL

Constructs	NULL
encoding	NULL
GST-GILZ	NULL
fusion	NULL
proteins	NULL
were	NULL
created	NULL
by	NULL
amplifying	NULL
the	NULL
GILZ	NULL
cDNA	NULL
and	NULL
fragments	NULL
1-60	NULL
,	NULL
61-104	NULL
,	NULL
61-187	NULL
,	NULL
105-137	NULL
,	NULL
and	NULL
ALZ	NULL
to	NULL
incorporate	NULL
BamHI	NULL
and	NULL
EcoRI	NULL
sites	NULL
and	NULL
transferring	NULL
them	NULL
into	NULL
pGEX-4T2	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

Transient	NULL
Transfections-In	NULL
transient	NULL
reporter	NULL
assays	NULL
,	NULL
2	NULL
X	NULL
10°	NULL
Jurkat	NULL
cells	NULL
in	NULL
0.2	NULL
ml	NULL
of	NULL
complete	NULL
medium	NULL
supplemented	NULL
with	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
were	NULL
electroporated	NULL
with	NULL
the	NULL
indicated	NULL
plasmids	NULL
with	NULL
a	NULL
GenePulser	NULL
(	NULL
Bio-Rad	NULL
)	NULL
using	NULL
960	NULL
microfarads	NULL
and	NULL
250	NULL
V.	NULL
Empty	NULL
parental	NULL
expression	NULL
plasmids	NULL
were	NULL
included	NULL
to	NULL
equalize	NULL
the	NULL
amount	NULL
of	NULL
DNA	NULL
used	NULL
in	NULL
each	NULL
cuvette	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
cultures	NULL
were	NULL
stimulated	NULL
with	NULL
20	NULL
ng/ml	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
and	NULL
1	NULL
ug/ml	NULL
ionomycin	NULL
.	NULL

Error	NULL
bars	NULL
represent	NULL
the	NULL
geometric	NULL
error	NULL
of	NULL
duplicate	NULL
transfections	NULL
.	NULL

Experiments	NULL
using	NULL
the	NULL
tetracycline-regulated	NULL
expression	NULL
system	NULL
were	NULL
performed	NULL
using	NULL
tetracycline-free	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
CLONTECH	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

1	NULL
ug	NULL
of	NULL
the	NULL
pecDNAA4-GILZ	NULL
constructs	NULL
,	NULL
0.5	NULL
ug	NULL
of	NULL
the	NULL
repressor-encoding	NULL
plasmid	NULL
peDNA6	NULL
,	NULL
and	NULL
2.5	NULL
ug	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
plasmids	NULL
were	NULL
used	NULL
.	NULL

Doxycycline	NULL
was	NULL
added	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
100	NULL
nM	NULL
.	NULL

The	NULL
base-line	NULL
activities	NULL
of	NULL
the	NULL
reporter	NULL
plasmids	NULL
were	NULL
generally	NULL
in	NULL
the	NULL
range	NULL
300	NULL
to	NULL
6000	NULL
relative	NULL
light	NULL
units	NULL
and	NULL
did	NULL
not	NULL
change	NULL
appreciably	NULL
when	NULL
GILZ	NULL
was	NULL
coexpressed	NULL
.	NULL

2	NULL
D.	NULL
Franchimont	NULL
,	NULL
J.	NULL
Galon	NULL
,	NULL
M.	NULL
S.	NULL
Vacchio	NULL
,	NULL
S.	NULL
Fan	NULL
,	NULL
R.	NULL
Visconti	NULL
,	NULL
D.	NULL
M.	NULL
Frucht	NULL
,	NULL
V.	NULL
Geenen	NULL
,	NULL
G.	NULL
P.	NULL
Chrousos	NULL
,	NULL
J.	NULL
D.	NULL
Ashwell	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
O'Shea	NULL
,	NULL
submitted	NULL
for	NULL
publication	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Inhibition	NULL
of	NULL
AP-1	NULL
by	NULL
GILZ	NULL
A	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Expression	NULL
of	NULL
GILZ	NULL
blocks	NULL
induction	NULL
of	NULL
the	NULL
FasL	NULL
promoter	NULL
and	NULL
its	NULL
Egr-regulated	NULL
enhancer	NULL
element	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
trans-	NULL
164	NULL
fected	NULL
with	NULL
luciferase-expressing	NULL
reporter	NULL
constructs	NULL
driven	NULL
by	NULL
the	NULL
511	NULL
base	NULL
pairs	NULL
of	NULL
human	NULL
FasL	NULL
promoter	NULL
(	NULL
A	NULL
)	NULL
,	NULL
the	NULL
Egr-re-sponsive	NULL
element	NULL
of	NULL
the	NULL
FasL	NULL
promoter	NULL
(	NULL
FLRE	NULL
)	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
a	NULL
GILZ-encoding	NULL
expression	NULL
plasmid	NULL
.	NULL

Empty	NULL
expression	NULL
vector	NULL
was	NULL
added	NULL
to	NULL
equalize	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
in	NULL
each	NULL
transfection	NULL
.	NULL

-	NULL
Individual	NULL
-	NULL
transfections	NULL
were	NULL
divided	NULL
into	NULL
two	NULL
parts	NULL
,	NULL
one	NULL
of	NULL
which	NULL
was	NULL
left	NULL
untreated	NULL
,	NULL
and	NULL
the	NULL
other	NULL
was	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
.	NULL

After	NULL
15	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
determined	NULL
.	NULL

Results	NULL
shown	NULL
are	NULL
the	NULL
mean	NULL
and	NULL
geometric	NULL
error	NULL
Fold	NULL
induction	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

A	NULL
B	NULL
EGR-2	NULL
EGR-3	NULL
FasL	NULL
.	NULL

12	NULL
-	NULL
12	NULL
4	NULL
.	NULL

8	NULL
4	NULL
8	NULL
.	NULL

4	NULL
.	NULL

4	NULL
|	NULL
of	NULL
duplicate	NULL
transfections	NULL
.	NULL

The	NULL
results	NULL
are	NULL
1	NULL
.	NULL

1	NULL
0	NULL
0.8	NULL
2	NULL
A	NULL
29605	NULL
FLRE	NULL
16	NULL
4	NULL
ug	NULL
GILZ	NULL
plasmid	NULL
C	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Expression	NULL
of	NULL
GILZ	NULL
blocks	NULL
FasL	NULL
induction	NULL
of	NULL
the	NULL
Egr-2	NULL
and	NULL
Egr-3	NULL
pro	NULL
moters	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
40	NULL
30	NULL
transfected	NULL
with	NULL
luciferase-expressing	NULL
re-oEsr	NULL
?	NULL

porter	NULL
constructs	NULL
driven	NULL
by	NULL
the	NULL
950	NULL
base	NULL
5	NULL
|	NULL
3	NULL
pairs	NULL
of	NULL
Egr-2	NULL
promoter	NULL
(	NULL
A	NULL
)	NULL
and	NULL
the	NULL
2.4	NULL
o	NULL
30	NULL
m	NULL
Egr	NULL
kilobase	NULL
pairs	NULL
of	NULL
Egr-3	NULL
promoter	NULL
(	NULL
B	NULL
)	NULL
along	NULL
8	NULL
20	NULL
4	NULL
with	NULL
the	NULL
GILZ-encoding	NULL
plasmid	NULL
and	NULL
ac-3	NULL
tivated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
.	NULL

C	NULL
,	NULL
the	NULL
Pg	NULL
20	NULL
3	NULL
511	NULL
base	NULL
pairs	NULL
of	NULL
FasL-dependent	NULL
re-a-	NULL
porter	NULL
was	NULL
activated	NULL
with	NULL
cotransfected	NULL
ke	NULL
10	NULL
Egr-2-	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
and	NULL
Egr-3	NULL
(	NULL
filled	NULL
bars	NULL
)	NULL
-©	NULL
10	NULL
3	NULL
expressing	NULL
plasmids	NULL
.	NULL

Results	NULL
are	NULL
ex-H-	NULL
pressed	NULL
as	NULL
fold	NULL
activity	NULL
determined	NULL
by	NULL
dividing	NULL
the	NULL
activity	NULL
obtained	NULL
with	NULL
the	NULL
Eigr-1	NULL
T	NULL
1	NULL
expressing	NULL
plasmid	NULL
by	NULL
that	NULL
obtained	NULL
with	NULL
0	NULL
1	NULL
3	NULL
i	NULL
1	NULL
3	NULL
0	NULL
2	NULL
A	NULL
the	NULL
parental	NULL
plasmid	NULL
pCB6	NULL
.	NULL

Results	NULL
X	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
inde-	NULL
.	NULL

pendent	NULL
experiments	NULL
.	NULL

ug	NULL
GILZ	NULL
plasmid	NULL
NFAT	NULL
TRE	NULL
300	NULL
4	NULL
50	NULL
4	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

The	NULL
NFAT	NULL
element	NULL
is	NULL
sensitive	NULL
to	NULL
GILZ	NULL
by	NULL
virtue	NULL
of	NULL
the	NULL
strong	NULL
a	NULL
40	NULL
A	NULL
sensitivity	NULL
of	NULL
the	NULL
associated	NULL
AP-l	NULL
elee	NULL
_	NULL
|C	NULL
ment	NULL
to	NULL
GILZ	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
tran-	NULL
t	NULL
200	NULL
4	NULL
siently	NULL
transfected	NULL
with	NULL
luciferase	NULL
re-	NULL
3	NULL
30	NULL
4	NULL
porter	NULL
constructs	NULL
for	NULL
NFAT	NULL
(	NULL
4	NULL
)	NULL
or	NULL
AP-1	NULL
g	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
lam	NULL
!	NULL

indicated	NULL
amounts	NULL
(	NULL
pg	NULL
)	NULL
of	NULL
expression	NULL
E	NULL
20	NULL
4	NULL
plasmids	NULL
encoding	NULL
GILZ	NULL
or	NULL
TAM-67	NULL
.	NULL

Re-	NULL
©	NULL
100	NULL
4	NULL
sults	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
H	NULL
experiments	NULL
.	NULL

10	NULL
4	NULL
1	NULL
+	NULL
1	NULL
+	NULL
0	NULL
0.8	NULL
24	NULL
0.8	NULL
24	NULL
0	NULL
0.8	NULL
24	NULL
-	NULL
0.8	NULL
%	NULL
24	NULL
L_	NULL
L	NULL
L_______	NULL
LLU	NULL
GILZ	NULL
TAM-67	NULL
GILZ	NULL
TAM-67	NULL
Northern	NULL
Blot	NULL
Analysis-Total	NULL
RNA	NULL
(	NULL
8	NULL
ug	NULL
)	NULL
was	NULL
separated	NULL
by	NULL
electrophoresis	NULL
through	NULL
a	NULL
1.5	NULL
%	NULL
agarose	NULL
gel	NULL
containing	NULL
6	NULL
%	NULL
formaldehyde	NULL
and	NULL
MOPS	NULL
buffer	NULL
(	NULL
Quality	NULL
Biological	NULL
,	NULL
Inc.	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

After	NULL
transfer	NULL
to	NULL
a	NULL
Genescreen	NULL
membrane	NULL
(	NULL
PerkinElmer	NULL
Life	NULL
Sciences	NULL
)	NULL
,	NULL
RNA	NULL
was	NULL
covalently	NULL
bound	NULL
by	NULL
UV	NULL
cross-linking	NULL
,	NULL
and	NULL
hybridization	NULL
with	NULL
*°P-la-	NULL
beled	NULL
cDNA	NULL
probes	NULL
was	NULL
carried	NULL
out	NULL
at	NULL
42	NULL
°C	NULL
in	NULL
5	NULL
%	NULL
SSPE	NULL
,	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
10	NULL
%	NULL
dextran	NULL
sulfate	NULL
,	NULL
and	NULL
50	NULL
%	NULL
formamide	NULL
(	NULL
Analytical	NULL
Biosciences	NULL
)	NULL
.	NULL

cDNAs	NULL
encoding	NULL
human	NULL
IL-2	NULL
and	NULL
glyceraldyhyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
were	NULL
used	NULL
as	NULL
probes	NULL
.	NULL

Final	NULL
washes	NULL
were	NULL
performed	NULL
at	NULL
65	NULL
°C	NULL
in	NULL
2X	NULL
SSPE	NULL
and	NULL
2	NULL
%	NULL
SDS	NULL
.	NULL

After	NULL
exposing	NULL
the	NULL
blot	NULL
to	NULL
detect	NULL
human	NULL
IL-2	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
29606	NULL
A	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

GILZ	NULL
expressed	NULL
from	NULL
a	NULL
doxy-	NULL
400	NULL
cycline-regulated	NULL
plasmid	NULL
inhibited	NULL
Inhibition	NULL
of	NULL
AP-1	NULL
by	NULL
GILZ	NULL
the	NULL
TRE	NULL
.	NULL

A	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
TRE-dependent	NULL
reporter	NULL
,	NULL
a	NULL
plas-	NULL
a	NULL
Untreated	NULL
m	NULL
Dox	NULL
mid	NULL
encoding	NULL
the	NULL
Tet	NULL
repressor	NULL
protein	NULL
,	NULL
300	NULL
4	NULL
and	NULL
the	NULL
Dox-regulated	NULL
expression	NULL
plasmid	NULL
either	NULL
empty	NULL
or	NULL
encoding	NULL
the	NULL
14-kDa	NULL
protein	NULL
or	NULL
the	NULL
17-kDa	NULL
protein	NULL
GILZ	NULL
.	NULL

Fold	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
after	NULL
stimulation	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
doxycycline	NULL
(	NULL
100	NULL
nM	NULL
)	NULL
was	NULL
determined	NULL
.	NULL

B	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
Dox	NULL
on	NULL
GILZ	NULL
and	NULL
TCR-£	NULL
expression	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
and	NULL
ionomycin	NULL
was	NULL
evaluated	NULL
by	NULL
Western	NULL
blot	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

200	NULL
A	NULL
Fold	NULL
induction	NULL
100	NULL
4	NULL
GILZ	NULL
mRNA	NULL
,	NULL
the	NULL
membrane	NULL
was	NULL
stripped	NULL
by	NULL
boiling	NULL
in	NULL
0.1	NULL
%	NULL
SSC	NULL
and	NULL
1	NULL
%	NULL
SDS	NULL
and	NULL
probed	NULL
for	NULL
GAPDH	NULL
.	NULL

Blots	NULL
were	NULL
visualized	NULL
using	NULL
a	NULL
Storm	NULL
Phosphor-Imager	NULL
and	NULL
ImageQuant	NULL
software	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

In	NULL
Vitro	NULL
Binding	NULL
Assays-Bacterially	NULL
expressed	NULL
glutathione	NULL
S-trans-ferase	NULL
(	NULL
GST	NULL
)	NULL
fusion	NULL
proteins	NULL
were	NULL
immobilized	NULL
on	NULL
glutathione-Sepha-rose	NULL
beads	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
between	NULL
the	NULL
GST	NULL
fusion	NULL
protein-coated	NULL
beads	NULL
and	NULL
°°S-labeled	NULL
proteins	NULL
were	NULL
performed	NULL
in	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
250	NULL
mM	NULL
KCl	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
and	NULL
20	NULL
%	NULL
glycerol	NULL
while	NULL
rotating	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
2	NULL
h.	NULL
Proteins	NULL
remaining	NULL
after	NULL
washing	NULL
the	NULL
beads	NULL
with	NULL
binding	NULL
buffer	NULL
were	NULL
eluted	NULL
by	NULL
boiling	NULL
in	NULL
sample	NULL
buffer	NULL
,	NULL
separated	NULL
by	NULL
electrophoresis	NULL
through	NULL
10	NULL
%	NULL
or	NULL
18.5	NULL
%	NULL
SDS-PAGE	NULL
gels	NULL
,	NULL
and	NULL
visualized	NULL
with	NULL
a	NULL
PhosphorImager	NULL
.	NULL

Electromobility	NULL
Shift	NULL
Assays-To	NULL
obtain	NULL
AP-1	NULL
,	NULL
the	NULL
murine	NULL
T	NULL
cell	NULL
hybridoma	NULL
MA	NULL
5.8	NULL
was	NULL
stimulated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
50	NULL
nM	NULL
PMA	NULL
.	NULL

Extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
,	NULL
as	NULL
was	NULL
the	NULL
binding	NULL
reaction	NULL
buffer	NULL
,	NULL
except	NULL
that	NULL
50	NULL
mM	NULL
NaCl	NULL
was	NULL
included	NULL
(	NULL
87	NULL
)	NULL
.	NULL

The	NULL
following	NULL
reagents	NULL
were	NULL
added	NULL
as	NULL
indicated	NULL
:	NULL
1	NULL
pmol	NULL
(	NULL
a	NULL
50-fold	NULL
excess	NULL
)	NULL
of	NULL
unlabeled	NULL
AP-1	NULL
or	NULL
NF-kB	NULL
oligonucleotides	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
Fos-specific	NULL
(	NULL
K-25	NULL
)	NULL
or	NULL
control	NULL
Egr-2-specific	NULL
antibodies	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
,	NULL
or	NULL
8	NULL
uM	NULL
GST	NULL
or	NULL
GST-GILZ	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
20	NULL
fmol	NULL
of	NULL
|°°PIdATP	NULL
end-labeled	NULL
AP-1	NULL
oligo-nucleotide	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reactions	NULL
,	NULL
which	NULL
were	NULL
allowed	NULL
to	NULL
incubate	NULL
for	NULL
an	NULL
additional	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
through	NULL
a	NULL
5	NULL
%	NULL
native	NULL
acrylamide	NULL
gel	NULL
run	NULL
at	NULL
100	NULL
V	NULL
in	NULL
0.5	NULL
%	NULL
TBE	NULL
for	NULL
1	NULL
h	NULL
and	NULL
visualized	NULL
with	NULL
a	NULL
PhosphorImager	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
oligonucleotides	NULL
used	NULL
were	NULL
AP-1	NULL
,	NULL
5-CTAGTGATGAGTCAGCCGGATC-3	NULL
'	NULL
,	NULL
and	NULL
NF-kB	NULL
,	NULL
5-TAGTTGAGGGGACTTTCCCAG-GCA-3	NULL
'	NULL
.	NULL

Western	NULL
Blotting-Samples	NULL
from	NULL
equivalent	NULL
numbers	NULL
of	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
sample	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
6.8	NULL
,	NULL
2	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
)	NULL
and	NULL
denatured	NULL
by	NULL
boiling	NULL
.	NULL

After	NULL
separation	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
the	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
probed	NULL
with	NULL
antibodies	NULL
,	NULL
and	NULL
developed	NULL
with	NULL
**	NULL
``	NULL
I-labeled	NULL
protein	NULL
A	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

Anti-GILZ	NULL
antibodies	NULL
were	NULL
used	NULL
at	NULL
a	NULL
dilution	NULL
of	NULL
1:200	NULL
.	NULL

The	NULL
anti-TCR-/-probed	NULL
blot	NULL
was	NULL
probed	NULL
with	NULL
rabbit	NULL
anti-mouse	NULL
Ig	NULL
(	NULL
H	NULL
+	NULL
L	NULL
)	NULL
antibodies	NULL
(	NULL
Jackson	NULL
Laboratories	NULL
,	NULL
Bar	NULL
Harbor	NULL
,	NULL
ME	NULL
)	NULL
.	NULL

RESULTS	NULL
Suppression	NULL
of	NULL
IL-2	NULL
Induction	NULL
by	NULL
Glucocorticoids	NULL
Requires	NULL
New	NULL
Protein	NULL
Synthesis-Transcription-independent	NULL
direct	NULL
interference	NULL
is	NULL
accepted	NULL
as	NULL
a	NULL
major	NULL
,	NULL
if	NULL
not	NULL
the	NULL
major	NULL
,	NULL
mechanism	NULL
by	NULL
which	NULL
glucocorticoids	NULL
suppress	NULL
transcription	NULL
of	NULL
responsive	NULL
genes	NULL
.	NULL

A	NULL
key	NULL
feature	NULL
of	NULL
this	NULL
phenomenon	NULL
is	NULL
that	NULL
suppression	NULL
should	NULL
occur	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
new	NULL
protein	NULL
synthesis	NULL
(	NULL
provided	NULL
that	NULL
induction	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
question	NULL
itself	NULL
does	NULL
not	NULL
rely	NULL
on	NULL
factors	NULL
that	NULL
require	NULL
de	NULL
novo	NULL
synthesis	NULL
)	NULL
.	NULL

IL-2	NULL
plays	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
the	NULL
immune	NULL
response	NULL
,	NULL
and	NULL
its	NULL
transcriptional	NULL
induction	NULL
in	NULL
T	NULL
cells	NULL
activated	NULL
in	NULL
vitro	NULL
can	NULL
be	NULL
inhibited	NULL
by	NULL
Dex	NULL
(	NULL
42	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
IL-2	NULL
transcription	NULL
largely	NULL
depends	NULL
on	NULL
constitutively	NULL
expressed	NULL
transcription	NULL
factors	NULL
and	NULL
thus	NULL
does	NULL
not	NULL
require	NULL
new	NULL
protein	NULL
synthesis	NULL
(	NULL
44	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
glucocorticoid-mediated	NULL
repression	NULL
of	NULL
IL-2	NULL
production	NULL
requires	NULL
new	NULL
protein	NULL
synthesis	NULL
,	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
were	NULL
DOX	NULL
+P	NULL
+	NULL
I	NULL
Untreated	NULL
P	NULL
+	NULL
I	NULL
DOX	NULL
alike	NULL
-	NULL
GILZ	NULL
___	NULL
_	NULL
heve	NULL
Vector	NULL
-	NULL
TCR-C	NULL
stimulated	NULL
for	NULL
3	NULL
h	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
Dex	NULL
and/or	NULL
the	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
,	NULL
at	NULL
which	NULL
time	NULL
IL-2	NULL
mRNA	NULL
levels	NULL
were	NULL
determined	NULL
by	NULL
Northern	NULL
blotting	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

PMA/ionomycin-induced	NULL
IL-2	NULL
mRNA	NULL
up-regulation	NULL
was	NULL
inhibited	NULL
by	NULL
cotreatment	NULL
with	NULL
Dex	NULL
(	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Treatment	NULL
with	NULL
CHX	NULL
did	NULL
not	NULL
induce	NULL
expression	NULL
of	NULL
IL-2	NULL
message	NULL
but	NULL
did	NULL
cause	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
activation-induced	NULL
level	NULL
(	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
.	NULL

This	NULL
increase	NULL
,	NULL
characteristic	NULL
of	NULL
early-response	NULL
genes	NULL
whose	NULL
transiently	NULL
elevated	NULL
mRNA	NULL
levels	NULL
are	NULL
prolonged	NULL
by	NULL
blocking	NULL
synthesis	NULL
of	NULL
presumed	NULL
destabilizing	NULL
proteins	NULL
,	NULL
has	NULL
been	NULL
described	NULL
as	NULL
``	NULL
super-induction	NULL
``	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Adding	NULL
CHX	NULL
to	NULL
Dex-stimulated	NULL
cells	NULL
restored	NULL
the	NULL
level	NULL
of	NULL
IL-2	NULL
mRNA	NULL
to	NULL
that	NULL
of	NULL
the	NULL
CHX-superinduced	NULL
cells	NULL
.	NULL

Note	NULL
that	NULL
although	NULL
CHX	NULL
treatment	NULL
itself	NULL
caused	NULL
a	NULL
reduction	NULL
in	NULL
GAPDH	NULL
,	NULL
as	NULL
reported	NULL
previously	NULL
(	NULL
46	NULL
)	NULL
,	NULL
the	NULL
GAPDH	NULL
levels	NULL
were	NULL
the	NULL
same	NULL
within	NULL
the	NULL
group	NULL
cultured	NULL
without	NULL
CHX	NULL
and	NULL
within	NULL
the	NULL
group	NULL
cultured	NULL
with	NULL
CHX	NULL
and	NULL
therefore	NULL
serves	NULL
as	NULL
a	NULL
loading	NULL
control	NULL
.	NULL

These	NULL
data	NULL
argue	NULL
against	NULL
a	NULL
strict	NULL
direct	NULL
interference	NULL
model	NULL
,	NULL
suggesting	NULL
instead	NULL
that	NULL
in	NULL
normal	NULL
T	NULL
cells	NULL
the	NULL
liganded	NULL
GR	NULL
induces	NULL
a	NULL
gene	NULL
whose	NULL
product	NULL
inhibits	NULL
transcription	NULL
of	NULL
IL-2	NULL
.	NULL

GILZ	NULL
Prevents	NULL
Activation-induced	NULL
Up-regulation	NULL
of	NULL
FasL	NULL
and	NULL
Inhibits	NULL
Induction	NULL
of	NULL
Egr-2	NULL
and	NULL
Egr-3	NULL
Transcription-Because	NULL
GILZ	NULL
is	NULL
among	NULL
the	NULL
most	NULL
responsive	NULL
of	NULL
the	NULL
genes	NULL
up-regulated	NULL
by	NULL
glucocorticoids	NULL
,	NULL
``	NULL
we	NULL
considered	NULL
the	NULL
possibility	NULL
that	NULL
it	NULL
might	NULL
be	NULL
a	NULL
general	NULL
mediator	NULL
of	NULL
glucocorticoid-induced	NULL
transcriptional	NULL
repression	NULL
.	NULL

Stable	NULL
expression	NULL
of	NULL
GILZ	NULL
in	NULL
T	NULL
cell	NULL
hybridoma	NULL
cells	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
block	NULL
activation-induced	NULL
up-regulation	NULL
of	NULL
FasL	NULL
(	NULL
34	NULL
)	NULL
.	NULL

To	NULL
begin	NULL
to	NULL
address	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
GILZ	NULL
acts	NULL
,	NULL
we	NULL
first	NULL
determined	NULL
whether	NULL
its	NULL
inhibitory	NULL
effect	NULL
on	NULL
FasL	NULL
induction	NULL
is	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL

GILZ	NULL
cDNA	NULL
was	NULL
transiently	NULL
expressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
together	NULL
with	NULL
FasL	NULL
promoter-driven	NULL
reporter	NULL
plasmids	NULL
.	NULL

When	NULL
cotransfected	NULL
with	NULL
an	NULL
empty	NULL
expression	NULL
plasmid	NULL
,	NULL
the	NULL
intact	NULL
FasL	NULL
reporter	NULL
plasmid	NULL
(	NULL
bases	NULL
-511	NULL
to	NULL
-1	NULL
relative	NULL
to	NULL
the	NULL
translation	NULL
initiation	NULL
site	NULL
)	NULL
was	NULL
strongly	NULL
induced	NULL
by	NULL
treatment	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
a	NULL
GILZ-expressing	NULL
plasmid	NULL
decreased	NULL
the	NULL
induction	NULL
in	NULL
a	NULL
dose-responsive	NULL
manner	NULL
,	NULL
indicating	NULL
that	NULL
GILZ	NULL
acts	NULL
on	NULL
transcription	NULL
.	NULL

This	NULL
region	NULL
of	NULL
the	NULL
fasL	NULL
gene	NULL
contains	NULL
a	NULL
number	NULL
of	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
that	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
FasL	NULL
regulation	NULL
,	NULL
including	NULL
sites	NULL
for	NULL
Egr	NULL
family	NULL
members	NULL
(	NULL
-214	NULL
to	NULL
-207	NULL
)	NULL
,	NULL
NFAT	NULL
(	NULL
-276	NULL
to	NULL
-272	NULL
)	NULL
,	NULL
and	NULL
NF-KB	NULL
(	NULL
-138	NULL
to	NULL
-128	NULL
)	NULL
(	NULL
37	NULL
,	NULL
47-50	NULL
)	NULL
.	NULL

We	NULL
have	NULL
found	NULL
that	NULL
much	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
FasL	NULL
promoter	NULL
depends	NULL
upon	NULL
the	NULL
Egr-binding	NULL
site	NULL
(	NULL
termed	NULL
the	NULL
FLRE	NULL
)	NULL
,	NULL
since	NULL
mutation	NULL
of	NULL
this	NULL
element	NULL
abrogated	NULL
activation-induced	NULL
reporter	NULL
up-regulation	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
effect	NULL
of	NULL
GILZ	NULL
on	NULL
FasL	NULL
promoter	NULL
activity	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Inhibition	NULL
of	NULL
AP-1	NULL
by	NULL
GILZ	NULL
A	NULL
GST-GILZ	NULL
t-3	NULL
BL	NULL
o	NULL
&	NULL
-o	NULL
)	NULL
A	NULL
--	NULL
&	NULL
m	NULL
t	NULL
9	NULL
L	NULL
8	NULL
4	NULL
i	NULL
U	NULL
-o-	NULL
5	NULL
-	NULL
©	NULL
.	NULL

w.	NULL
-	NULL
c-Jun	NULL
“	NULL
ﬁn	NULL
_-	NULL
c-Fos	NULL
ist	NULL
a	NULL
8	NULL
20	NULL
£8	NULL
Z	NULL
NFATp	NULL
-	NULL
«	NULL
ee	NULL
ww	NULL
-NFATA4	NULL
GST-C	NULL
GILZ	NULL
m-+o	NULL
“	NULL
N	NULL
2	NULL
§	NULL
2	NULL
a	NULL
-	NULL
0	NULL
-	NULL
.	NULL

<	NULL
r	NULL
awe	NULL
--	NULL
-GILZ	NULL
O	NULL
D	NULL
a	NULL
50	NULL
.o	NULL
S	NULL
°	NULL
a	NULL
£	NULL
§	NULL
9	NULL
€	NULL
ToY¥	NULL
Sg	NULL
f	NULL
bo	NULL
Eb	NULL
o	NULL
&	NULL
A	NULL
kL	NULL
f	NULL
o	NULL
m	NULL
m	NULL
Z	NULL
4	NULL
Z	NULL
4	NULL
V	NULL
O	NULL
O	NULL
AP-1	NULL
CO	NULL
t_	NULL
a	NULL
C	NULL
_	NULL
al	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

GILZ	NULL
interacts	NULL
with	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
through	NULL
a	NULL
site	NULL
outside	NULL
of	NULL
its	NULL
leucine	NULL
zipper	NULL
,	NULL
which	NULL
itself	NULL
can	NULL
mediate	NULL
ho-modimerization	NULL
.	NULL

A-C	NULL
,	NULL
the	NULL
indicated	NULL
*°S-labeled	NULL
in	NULL
vitro	NULL
translated	NULL
proteins	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
GST-GILZ	NULL
fusion	NULL
proteins	NULL
.	NULL

Interacting	NULL
proteins	NULL
remaining	NULL
after	NULL
washing	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

The	NULL
lanes	NULL
labeled	NULL
Input	NULL
represent	NULL
10	NULL
%	NULL
of	NULL
the	NULL
in	NULL
vitro	NULL
translated	NULL
material	NULL
offered	NULL
to	NULL
the	NULL
GST-coated	NULL
beads	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
six	NULL
(	NULL
c-Fos	NULL
)	NULL
,	NULL
four	NULL
(	NULL
c-Jun	NULL
)	NULL
,	NULL
three	NULL
(	NULL
NFATs	NULL
)	NULL
,	NULL
and	NULL
5	NULL
(	NULL
GILZ	NULL
)	NULL
experiments	NULL
.	NULL

D	NULL
,	NULL
GILZ	NULL
inhibits	NULL
binding	NULL
of	NULL
AP-1	NULL
to	NULL
its	NULL
cognate	NULL
DNA	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
the	NULL
indicated	NULL
reagents	NULL
on	NULL
binding	NULL
of	NULL
AP-1	NULL
to	NULL
a	NULL
consensus	NULL
AP-1	NULL
element	NULL
was	NULL
determined	NULL
by	NULL
electromobility	NULL
shift	NULL
assay	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

Ab	NULL
,	NULL
antibody	NULL
.	NULL

was	NULL
due	NULL
to	NULL
interference	NULL
with	NULL
the	NULL
Egr-mediated	NULL
pathway	NULL
,	NULL
a	NULL
reporter	NULL
driven	NULL
by	NULL
a	NULL
promoter	NULL
containing	NULL
just	NULL
the	NULL
FasL	NULL
FLRE	NULL
(	NULL
-220	NULL
to	NULL
-205	NULL
)	NULL
driving	NULL
the	NULL
proximal	NULL
3	NULL
'	NULL
region	NULL
of	NULL
the	NULL
FasL	NULL
promoter	NULL
(	NULL
37	NULL
)	NULL
was	NULL
tested	NULL
for	NULL
sensitivity	NULL
to	NULL
the	NULL
GILZ-expressing	NULL
29607	NULL
plasmid	NULL
.	NULL

GILZ	NULL
inhibited	NULL
the	NULL
Egr-2/3-dependent	NULL
FLRE-driven	NULL
reporter	NULL
as	NULL
well	NULL
as	NULL
it	NULL
did	NULL
the	NULL
entire	NULL
FasL	NULL
promoter	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
GILZ	NULL
exerts	NULL
its	NULL
effects	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
by	NULL
preventing	NULL
the	NULL
Egr-2/3-mediated	NULL
pathway	NULL
of	NULL
FasL	NULL
transcriptional	NULL
induction	NULL
.	NULL

Egr-2	NULL
and	NULL
Egr-3	NULL
are	NULL
synthesized	NULL
de	NULL
novo	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
their	NULL
enforced	NULL
expression	NULL
by	NULL
transient	NULL
transfection	NULL
is	NULL
sufficient	NULL
to	NULL
induce	NULL
FasL	NULL
reporter	NULL
activity	NULL
and	NULL
induction	NULL
of	NULL
endog-enous	NULL
FasL	NULL
mRNA	NULL
(	NULL
37	NULL
)	NULL
.	NULL

GILZ	NULL
could	NULL
exert	NULL
its	NULL
effect	NULL
on	NULL
the	NULL
FasL	NULL
transcription	NULL
by	NULL
preventing	NULL
their	NULL
de	NULL
novo	NULL
synthesis	NULL
of	NULL
Eigr	NULL
proteins	NULL
,	NULL
or	NULL
it	NULL
could	NULL
block	NULL
their	NULL
activity	NULL
at	NULL
a	NULL
posttranslational	NULL
step	NULL
,	NULL
for	NULL
example	NULL
at	NULL
the	NULL
site	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
FasL	NULL
promoter	NULL
.	NULL

To	NULL
distinguish	NULL
between	NULL
these	NULL
possibilities	NULL
,	NULL
the	NULL
GILZ	NULL
expression	NULL
vector	NULL
was	NULL
cotransfected	NULL
with	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
driven	NULL
by	NULL
the	NULL
Egr-2	NULL
or	NULL
the	NULL
Egr-3	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

PMA	NULL
and	NULL
ionomycin	NULL
induction	NULL
of	NULL
both	NULL
Egr	NULL
promoter-driven	NULL
reporters	NULL
was	NULL
blocked	NULL
by	NULL
coexpressed	NULL
GILZ	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
when	NULL
transcriptional	NULL
up-regulation	NULL
of	NULL
the	NULL
FasL	NULL
promoter	NULL
was	NULL
induced	NULL
by	NULL
enforced	NULL
expression	NULL
Egr-2	NULL
or	NULL
Egr-3	NULL
alone	NULL
,	NULL
coexpres-sion	NULL
of	NULL
GILZ	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
reporter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
GILZ	NULL
does	NULL
not	NULL
interfere	NULL
with	NULL
Egr-mediated	NULL
up-regulation	NULL
of	NULL
FasL	NULL
directly	NULL
but	NULL
rather	NULL
indirectly	NULL
by	NULL
preventing	NULL
the	NULL
transcriptional	NULL
induction	NULL
of	NULL
Egr-2	NULL
and	NULL
Egr-3	NULL
.	NULL

GILZ	NULL
Blocks	NULL
NFAT/AP-1	NULL
Activity-The	NULL
induction	NULL
of	NULL
Egr-2	NULL
and	NULL
Egr-3	NULL
by	NULL
T	NULL
cell	NULL
activation	NULL
is	NULL
mediated	NULL
by	NULL
NFAT-binding	NULL
elements	NULL
in	NULL
their	NULL
promoters	NULL
(	NULL
88	NULL
,	NULL
39	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
effect	NULL
of	NULL
GILZ	NULL
on	NULL
Egr-2/3	NULL
expression	NULL
could	NULL
be	NULL
due	NULL
to	NULL
interference	NULL
with	NULL
NFAT	NULL
signaling	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
an	NULL
NFAT	NULL
reporter	NULL
with	NULL
or	NULL
without	NULL
GILZ	NULL
cDNA	NULL
and	NULL
activated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
.	NULL

GILZ	NULL
inhibited	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
NFAT	NULL
reporter	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

NFAT-binding	NULL
elements	NULL
are	NULL
typically	NULL
found	NULL
adjacent	NULL
to	NULL
binding	NULL
sites	NULL
for	NULL
AP-1	NULL
(	NULL
also	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
TRE	NULL
or	NULL
TPA-responsive	NULL
element	NULL
)	NULL
,	NULL
and	NULL
the	NULL
affinity	NULL
of	NULL
each	NULL
factor	NULL
for	NULL
its	NULL
binding	NULL
site	NULL
is	NULL
enhanced	NULL
by	NULL
binding	NULL
of	NULL
the	NULL
other	NULL
.	NULL

All	NULL
four	NULL
NFAT	NULL
family	NULL
members	NULL
(	NULL
NFATp	NULL
,	NULL
-c	NULL
,	NULL
-2	NULL
,	NULL
and	NULL
-4	NULL
)	NULL
can	NULL
participate	NULL
in	NULL
cooperative	NULL
binding	NULL
to	NULL
the	NULL
TRE-adjacent	NULL
NFAT	NULL
sites	NULL
.	NULL

c-Jun	NULL
most	NULL
commonly	NULL
occupies	NULL
the	NULL
side	NULL
of	NULL
the	NULL
TRE	NULL
nearest	NULL
to	NULL
NFAT	NULL
(	NULL
51	NULL
)	NULL
,	NULL
although	NULL
NFAT	NULL
makes	NULL
contacts	NULL
with	NULL
both	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
(	NULL
52	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
as	NULL
reported	NULL
previously	NULL
(	NULL
40	NULL
)	NULL
,	NULL
the	NULL
NFAT	NULL
reporter	NULL
construct	NULL
was	NULL
also	NULL
inhibited	NULL
by	NULL
a	NULL
dominant-negative	NULL
mutant	NULL
of	NULL
c-Jun	NULL
(	NULL
TAM-67	NULL
)	NULL
to	NULL
a	NULL
similar	NULL
extent	NULL
as	NULL
GILZ	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
,	NULL
raising	NULL
the	NULL
possibility	NULL
that	NULL
GILZ	NULL
in	NULL
fact	NULL
interferes	NULL
with	NULL
the	NULL
AP-1	NULL
component	NULL
of	NULL
the	NULL
NFAT-AP-1	NULL
complex	NULL
.	NULL

To	NULL
explore	NULL
this	NULL
possibility	NULL
,	NULL
a	NULL
reporter	NULL
driven	NULL
by	NULL
the	NULL
proximal	NULL
TRE	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
40	NULL
,	NULL
53	NULL
)	NULL
was	NULL
introduced	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
;	NULL
its	NULL
induction	NULL
by	NULL
PMA	NULL
and	NULL
ionomycin	NULL
was	NULL
abolished	NULL
by	NULL
GILZ	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

To	NULL
characterize	NULL
further	NULL
the	NULL
effect	NULL
of	NULL
GILZ	NULL
on	NULL
AP-1	NULL
activity	NULL
,	NULL
GILZ	NULL
cDNA	NULL
was	NULL
cloned	NULL
into	NULL
a	NULL
tetracycline	NULL
(	NULL
Tet	NULL
)	NULL
-regulated	NULL
expression	NULL
vector	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
coexpressed	NULL
Tet	NULL
repressor	NULL
protein	NULL
with	NULL
the	NULL
Tet	NULL
analog	NULL
doxycycline	NULL
(	NULL
Dox	NULL
)	NULL
causes	NULL
its	NULL
dissociation	NULL
from	NULL
the	NULL
operator	NULL
of	NULL
the	NULL
expression	NULL
vector	NULL
and	NULL
allows	NULL
transcription	NULL
by	NULL
the	NULL
full-length	NULL
cytomegalovirus	NULL
promoter	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
Tet-regulated	NULL
GILZ	NULL
expression	NULL
plasmid	NULL
,	NULL
the	NULL
repressor-encoding	NULL
plasmid	NULL
,	NULL
and	NULL
the	NULL
TRE	NULL
reporter	NULL
plasmid	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
empty	NULL
Tet-respon-sive	NULL
expression	NULL
plasmid	NULL
,	NULL
PMA	NULL
and	NULL
ionomycin	NULL
caused	NULL
a	NULL
100-fold	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
,	NULL
which	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
Dox	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

When	NULL
the	NULL
GILZ-encoding	NULL
Tet-respon-sive	NULL
plasmid	NULL
was	NULL
cotransfected	NULL
,	NULL
there	NULL
was	NULL
a	NULL
small	NULL
reduction	NULL
in	NULL
activation-induced	NULL
AP-1	NULL
activity	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Dox	NULL
.	NULL

Adding	NULL
Dox	NULL
almost	NULL
completely	NULL
inhibited	NULL
induction	NULL
of	NULL
AP-1	NULL
activity	NULL
.	NULL

The	NULL
inhibitory	NULL
effect	NULL
of	NULL
Dox	NULL
was	NULL
accompanied	NULL
by	NULL
increased	NULL
expression	NULL
of	NULL
GILZ	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

An	NULL
irrelevant	NULL
protein	NULL
(	NULL
the	NULL
&	NULL
chain	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
)	NULL
encoded	NULL
by	NULL
the	NULL
Tet-regulated	NULL
plasmid	NULL
was	NULL
similarly	NULL
induced	NULL
by	NULL
Dox	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
and	NULL
ionomycin	NULL
but	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
stimulation	NULL
of	NULL
the	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
29608	NULL
A	NULL
TRE	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

GILZ	NULL
inhibits	NULL
the	NULL
IL-2	NULL
promoter	NULL
and	NULL
the	NULL
TRE	NULL
reporter	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
dimerization	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
driven	NULL
by	NULL
the	NULL
TRE	NULL
and	NULL
the	NULL
0.4	NULL
kilobase	NULL
pairs	NULL
of	NULL
human	NULL
IL-2	NULL
promoter	NULL
.	NULL

Plasmids	NULL
encoding	NULL
full-length	NULL
GILZ	NULL
,	NULL
a	NULL
GILZ	NULL
mutant	NULL
in	NULL
which	NULL
the	NULL
leucine	NULL
zipper	NULL
domain	NULL
was	NULL
deleted	NULL
(	NULL
amino	NULL
acids	NULL
76-96	NULL
)	NULL
,	NULL
or	NULL
the	NULL
empty	NULL
parental	NULL
plasmid	NULL
were	NULL
cotransfected	NULL
,	NULL
and	NULL
activity	NULL
was	NULL
analyzed	NULL
as	NULL
above	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

50	NULL
7	NULL
40	NULL
30	NULL
20	NULL
{	NULL
4	NULL
10	NULL
4	NULL
Fold	NULL
induction	NULL
1	NULL
pCI	NULL
TRE	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
wherein	NULL
GILZ	NULL
inhibits	NULL
the	NULL
activity	NULL
of	NULL
AP-1	NULL
,	NULL
which	NULL
impairs	NULL
NFAT/AP-1	NULL
signaling	NULL
and	NULL
leads	NULL
to	NULL
reduced	NULL
expression	NULL
of	NULL
Egr-2	NULL
,	NULL
Egr-3	NULL
,	NULL
and	NULL
FasL	NULL
.	NULL

GILZ	NULL
Interacts	NULL
with	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
through	NULL
Its	NULL
N-terminal	NULL
Portion-Because	NULL
GILZ	NULL
inhibited	NULL
activation-induced	NULL
AP-1	NULL
activity	NULL
and	NULL
contains	NULL
a	NULL
leucine	NULL
zipper	NULL
domain	NULL
,	NULL
the	NULL
possibility	NULL
was	NULL
considered	NULL
that	NULL
GILZ	NULL
might	NULL
dimerize	NULL
with	NULL
the	NULL
leucine	NULL
zipper-containing	NULL
AP-1	NULL
constituents	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
.	NULL

In	NULL
vitro	NULL
translated	NULL
*°S-labeled	NULL
c-Fos	NULL
or	NULL
c-Jun	NULL
were	NULL
offered	NULL
to	NULL
immobilized	NULL
GST	NULL
fusion	NULL
proteins	NULL
.	NULL

In	NULL
vitro	NULL
translated	NULL
c-Jun	NULL
is	NULL
represented	NULL
by	NULL
the	NULL
major	NULL
lower	NULL
band	NULL
,	NULL
with	NULL
two	NULL
minor	NULL
upper	NULL
bands	NULL
that	NULL
may	NULL
be	NULL
the	NULL
products	NULL
of	NULL
in-frame	NULL
upstream	NULL
translation	NULL
initiation	NULL
from	NULL
the	NULL
polylinker	NULL
region	NULL
of	NULL
the	NULL
plasmid	NULL
presumably	NULL
containing	NULL
c-Jun	NULL
,	NULL
and	NULL
thus	NULL
also	NULL
bind	NULL
GST-GILZ	NULL
.	NULL

There	NULL
was	NULL
only	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
nonspecific	NULL
binding	NULL
of	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
to	NULL
GST	NULL
protein	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

64	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
both	NULL
proteins	NULL
were	NULL
retained	NULL
by	NULL
immobilized	NULL
GST-GILZ	NULL
.	NULL

GST-GILZ	NULL
did	NULL
not	NULL
interact	NULL
with	NULL
°58-labeled	NULL
NFATp	NULL
or	NULL
NFAT4	NULL
,	NULL
two	NULL
isoforms	NULL
of	NULL
NFAT	NULL
that	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
Fas	NULL
ligand	NULL
regulation	NULL
(	NULL
38	NULL
)	NULL
,	NULL
supporting	NULL
the	NULL
notion	NULL
that	NULL
the	NULL
target	NULL
of	NULL
GILZ	NULL
is	NULL
in	NULL
fact	NULL
AP-1	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

To	NULL
map	NULL
the	NULL
site	NULL
of	NULL
interaction	NULL
in	NULL
GILZ	NULL
,	NULL
fusion	NULL
proteins	NULL
were	NULL
constructed	NULL
using	NULL
three	NULL
non-overlapping	NULL
segments	NULL
of	NULL
GILZ	NULL
,	NULL
each	NULL
consisting	NULL
of	NULL
roughly	NULL
a	NULL
third	NULL
of	NULL
the	NULL
full-length	NULL
protein	NULL
.	NULL

The	NULL
boundaries	NULL
of	NULL
these	NULL
segments	NULL
were	NULL
determined	NULL
by	NULL
estimating	NULL
each	NULL
end	NULL
of	NULL
the	NULL
a-helical	NULL
region	NULL
containing	NULL
the	NULL
leucine	NULL
zipper	NULL
domain	NULL
with	NULL
an	NULL
a-helical	NULL
prediction	NULL
program	NULL
(	NULL
``	NULL
The	NULL
PSA	NULL
Protein	NULL
Structure	NULL
Prediction	NULL
Server	NULL
,	NULL
``	NULL
bmere-www.bu.edu/psa/	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
both	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
were	NULL
efficiently	NULL
retained	NULL
by	NULL
the	NULL
N-terminal	NULL
portion	NULL
of	NULL
GILZ-	NULL
(	NULL
1-60	NULL
)	NULL
,	NULL
which	NULL
lacks	NULL
the	NULL
leucine	NULL
zipper	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

Neither	NULL
c-Fos	NULL
nor	NULL
c-Jun	NULL
bound	NULL
the	NULL
C-terminal	NULL
third	NULL
(	NULL
residues	NULL
105-137	NULL
)	NULL
or	NULL
two-thirds	NULL
(	NULL
residues	NULL
61-137	NULL
)	NULL
of	NULL
the	NULL
molecule	NULL
.	NULL

GST-	NULL
(	NULL
61-137	NULL
)	NULL
retained	NULL
the	NULL
ability	NULL
to	NULL
dimerize	NULL
with	NULL
translated	NULL
GILZ	NULL
via	NULL
the	NULL
leucine	NULL
zipper	NULL
,	NULL
arguing	NULL
that	NULL
the	NULL
distal	NULL
two-thirds	NULL
of	NULL
the	NULL
molecule	NULL
was	NULL
properly	NULL
folded	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
given	NULL
the	NULL
lack	NULL
of	NULL
a	NULL
requirement	NULL
for	NULL
the	NULL
GILZ	NULL
leucine	NULL
zipper	NULL
to	NULL
bind	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
,	NULL
the	NULL
AP-1	NULL
components	NULL
did	NULL
not	NULL
bind	NULL
the	NULL
isolated	NULL
central	NULL
domain	NULL
of	NULL
GILZ	NULL
that	NULL
contains	NULL
the	NULL
leucine	NULL
zipper	NULL
(	NULL
residues	NULL
61-104	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
GILZ	NULL
leucine	NULL
zipper	NULL
is	NULL
in	NULL
fact	NULL
nonfunc-tional	NULL
.	NULL

One	NULL
way	NULL
to	NULL
test	NULL
this	NULL
is	NULL
to	NULL
determine	NULL
if	NULL
GILZ	NULL
can	NULL
form	NULL
leucine	NULL
zipper-dependent	NULL
homodimers	NULL
.	NULL

*°S-Labeled	NULL
GILZ	NULL
was	NULL
incubated	NULL
with	NULL
GILZ	NULL
fusion	NULL
proteins	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
GILZ	NULL
bound	NULL
to	NULL
GST-GILZ	NULL
.	NULL

Deleting	NULL
GILZ	NULL
residues	NULL
76-96	NULL
,	NULL
Inhibition	NULL
of	NULL
AP-1	NULL
by	NULL
GILZ	NULL
IL-2	NULL
80	NULL
60	NULL
4	NULL
40	NULL
20	NULL
1	NULL
.	NULL

GILZ	NULL
-	NULL
ALZ	NULL
pCI	NULL
_	NULL
GILZ	NULL
-	NULL
ALZ	NULL
which	NULL
constitute	NULL
three	NULL
turns	NULL
of	NULL
the	NULL
leucine	NULL
zipper	NULL
,	NULL
abrogated	NULL
the	NULL
interaction	NULL
.	NULL

GILZ	NULL
also	NULL
bound	NULL
to	NULL
the	NULL
related	NULL
product	NULL
of	NULL
the	NULL
transforming	NULL
growth	NULL
factor-B-induced	NULL
gene	NULL
TSC-22	NULL
immobilized	NULL
by	NULL
fusion	NULL
to	NULL
GST	NULL
in	NULL
a	NULL
leucine	NULL
zipper-dependent	NULL
fashion	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
leucine	NULL
zipper	NULL
of	NULL
GILZ	NULL
may	NULL
be	NULL
selective	NULL
for	NULL
a	NULL
particular	NULL
subclass	NULL
of	NULL
leucine	NULL
zippers	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
GILZ	NULL
on	NULL
the	NULL
interaction	NULL
of	NULL
AP-1	NULL
with	NULL
its	NULL
target	NULL
DNA	NULL
was	NULL
tested	NULL
in	NULL
an	NULL
electromobility	NULL
supershift	NULL
assay	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6D	NULL
,	NULL
extracts	NULL
of	NULL
a	NULL
PMA-stimulated	NULL
T	NULL
cell	NULL
hybridoma	NULL
bound	NULL
DNA	NULL
containing	NULL
a	NULL
consensus	NULL
AP-1-binding	NULL
site	NULL
.	NULL

The	NULL
shifted	NULL
band	NULL
was	NULL
effectively	NULL
competed	NULL
for	NULL
by	NULL
unlabeled	NULL
cognate	NULL
AP-1-binding	NULL
sequence	NULL
(	NULL
AP-1	NULL
oligonucleotides	NULL
)	NULL
but	NULL
not	NULL
an	NULL
NF-	NULL
«	NULL
B-binding	NULL
sequence	NULL
(	NULL
NF-kB	NULL
oligonucleotides	NULL
)	NULL
.	NULL

Further-more	NULL
,	NULL
anti-Fos	NULL
antibody	NULL
but	NULL
not	NULL
a	NULL
control	NULL
antibody	NULL
(	NULL
anti-Egr-2	NULL
)	NULL
reduced	NULL
the	NULL
amount	NULL
of	NULL
bound	NULL
AP-1	NULL
.	NULL

Incubation	NULL
of	NULL
the	NULL
extracts	NULL
with	NULL
GST-GILZ	NULL
but	NULL
not	NULL
an	NULL
equimolar	NULL
amount	NULL
of	NULL
GST	NULL
greatly	NULL
reduced	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
shifted	NULL
band	NULL
,	NULL
indicating	NULL
that	NULL
,	NULL
at	NULL
least	NULL
under	NULL
these	NULL
conditions	NULL
,	NULL
GILZ	NULL
interferes	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
active	NULL
AP-1	NULL
to	NULL
its	NULL
cognate	NULL
DNA	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
support	NULL
a	NULL
model	NULL
in	NULL
which	NULL
a	NULL
GILZ	NULL
homodimer	NULL
interacts	NULL
with	NULL
AP-1	NULL
components	NULL
and	NULL
prevents	NULL
binding	NULL
to	NULL
DNA	NULL
.	NULL

The	NULL
Leucine	NULL
Zipper	NULL
Motif	NULL
of	NULL
GILZ	NULL
Is	NULL
Not	NULL
Required	NULL
for	NULL
Transcriptional	NULL
Inhibition-The	NULL
initial	NULL
observation	NULL
in	NULL
this	NULL
study	NULL
was	NULL
that	NULL
repression	NULL
of	NULL
IL-2	NULL
by	NULL
Dex	NULL
depended	NULL
on	NULL
new	NULL
protein	NULL
synthesis	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
GILZ	NULL
could	NULL
serve	NULL
as	NULL
such	NULL
an	NULL
induced	NULL
protein	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
GILZ	NULL
to	NULL
block	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
was	NULL
tested	NULL
.	NULL

GILZ	NULL
blocked	NULL
the	NULL
PMA-	NULL
and	NULL
ionomycin-induced	NULL
up-regulation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
leucine	NULL
zipper	NULL
of	NULL
GILZ	NULL
did	NULL
not	NULL
directly	NULL
participate	NULL
in	NULL
direct	NULL
binding	NULL
to	NULL
c-Fos	NULL
or	NULL
c-Jun	NULL
,	NULL
its	NULL
role	NULL
in	NULL
the	NULL
repressive	NULL
function	NULL
of	NULL
GILZ	NULL
was	NULL
examined	NULL
.	NULL

The	NULL
GILZ	NULL
mutant	NULL
lacking	NULL
the	NULL
leucine	NULL
zipper	NULL
domain	NULL
was	NULL
nearly	NULL
as	NULL
effective	NULL
as	NULL
wild	NULL
type	NULL
GILZ	NULL
at	NULL
inhibiting	NULL
both	NULL
the	NULL
TRE	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
and	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
the	NULL
repressive	NULL
activity	NULL
of	NULL
GILZ	NULL
resides	NULL
outside	NULL
of	NULL
the	NULL
leucine	NULL
zipper	NULL
.	NULL

Further-more	NULL
,	NULL
because	NULL
a	NULL
leucine	NULL
zipper-bound	NULL
partner	NULL
protein	NULL
is	NULL
not	NULL
required	NULL
for	NULL
GILZ	NULL
to	NULL
exhibit	NULL
inhibitory	NULL
activity	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
GILZ	NULL
can	NULL
function	NULL
as	NULL
a	NULL
monomer	NULL
.	NULL

DISCUSSION	NULL
Glucocorticoids	NULL
influence	NULL
metabolic	NULL
and	NULL
functional	NULL
activities	NULL
in	NULL
almost	NULL
all	NULL
cell	NULL
types	NULL
.	NULL

As	NULL
such	NULL
a	NULL
versatile	NULL
molecule	NULL
it	NULL
is	NULL
likely	NULL
to	NULL
have	NULL
diverse	NULL
modes	NULL
of	NULL
action	NULL
.	NULL

Although	NULL
the	NULL
GR	NULL
possesses	NULL
strong	NULL
transcriptional	NULL
activity	NULL
,	NULL
its	NULL
suppressive	NULL
effects	NULL
,	NULL
in	NULL
par	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Inhibition	NULL
of	NULL
AP-1	NULL
by	NULL
GILZ	NULL
ticular	NULL
those	NULL
mediated	NULL
by	NULL
passively	NULL
obstructing	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
have	NULL
recently	NULL
received	NULL
a	NULL
great	NULL
deal	NULL
of	NULL
atten-tion	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
report	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
their	NULL
ability	NULL
to	NULL
promote	NULL
direct	NULL
interactions	NULL
between	NULL
the	NULL
GR	NULL
and	NULL
target	NULL
transcription	NULL
factors	NULL
,	NULL
glucocorticoid	NULL
suppression	NULL
of	NULL
normal	NULL
T	NULL
cell	NULL
cytokine	NULL
production	NULL
may	NULL
also	NULL
depend	NULL
on	NULL
a	NULL
contribution	NULL
from	NULL
GR-mediated	NULL
transactivation	NULL
,	NULL
leading	NULL
to	NULL
transcription	NULL
of	NULL
a	NULL
gene	NULL
whose	NULL
product	NULL
can	NULL
itself	NULL
carry	NULL
out	NULL
direct	NULL
interference	NULL
.	NULL

Direct	NULL
interference	NULL
between	NULL
the	NULL
GR	NULL
and	NULL
transcriptional	NULL
ac-tivators	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
glucocorticoid	NULL
repression	NULL
of	NULL
inflammatory	NULL
mediators	NULL
such	NULL
as	NULL
collagenase	NULL
(	NULL
for	NULL
AP-1	NULL
)	NULL
and	NULL
IL-6	NULL
(	NULL
for	NULL
NF-kB	NULL
)	NULL
(	NULL
24	NULL
,	NULL
32	NULL
)	NULL
,	NULL
which	NULL
can	NULL
be	NULL
produced	NULL
by	NULL
non-lym-phoid	NULL
cells	NULL
.	NULL

A	NULL
similar	NULL
mechanism	NULL
was	NULL
invoked	NULL
to	NULL
account	NULL
for	NULL
glucocorticoid	NULL
repression	NULL
of	NULL
IL-2	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
based	NULL
on	NULL
the	NULL
observation	NULL
that	NULL
occupancy	NULL
of	NULL
a	NULL
GR	NULL
lacking	NULL
the	NULL
N-terminal	NULL
transactivation	NULL
domain	NULL
was	NULL
able	NULL
to	NULL
inhibit	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
54	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
study	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
was	NULL
performed	NULL
with	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
some	NULL
signaling	NULL
pathways	NULL
are	NULL
aberrant	NULL
,	NULL
for	NULL
example	NULL
the	NULL
lack	NULL
of	NULL
the	NULL
phosphatase	NULL
PTEN	NULL
and	NULL
the	NULL
resulting	NULL
constitutive	NULL
activity	NULL
of	NULL
phosphatidylinositol	NULL
3-kinase	NULL
(	NULL
55	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
activation-induced	NULL
up-regulation	NULL
of	NULL
IL-2	NULL
mRNA	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
is	NULL
blocked	NULL
by	NULL
cycloheximide	NULL
,	NULL
``	NULL
suggesting	NULL
that	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
unlike	NULL
normal	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
depends	NULL
on	NULL
newly	NULL
synthesized	NULL
proteins	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
an	NULL
N-terminal	NULL
deletion	NULL
mutant	NULL
GR	NULL
,	NULL
similar	NULL
to	NULL
that	NULL
used	NULL
by	NULL
Northrop	NULL
et	NULL
al	NULL
.	NULL

(	NULL
54	NULL
)	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
transactivate	NULL
a	NULL
GRE	NULL
in	NULL
a	NULL
Dex-dependent	NULL
manner	NULL
in	NULL
yeast	NULL
(	NULL
56	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
when	NULL
a	NULL
GR	NULL
mutant	NULL
in	NULL
the	NULL
C-terminal	NULL
zinc	NULL
finger	NULL
that	NULL
was	NULL
defective	NULL
in	NULL
transactivation	NULL
and	NULL
yet	NULL
capable	NULL
of	NULL
mediating	NULL
suppression	NULL
(	NULL
20	NULL
)	NULL
,	NULL
another	NULL
transactivation-defective	NULL
mutant	NULL
,	NULL
and	NULL
the	NULL
dimerization-deficient	NULL
mutant	NULL
GR	NULL
were	NULL
stably	NULL
expressed	NULL
in	NULL
SAOS2	NULL
osteosarcoma	NULL
cells	NULL
,	NULL
treatment	NULL
with	NULL
Dex	NULL
caused	NULL
growth-arrest	NULL
and	NULL
induction	NULL
of	NULL
one	NULL
or	NULL
both	NULL
of	NULL
the	NULL
cyclin-dependent	NULL
kinase	NULL
inhibitors	NULL
p21	NULL
``	NULL
and	NULL
p27	NULL
``	NULL
to	NULL
a	NULL
degree	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
GR	NULL
(	NULL
56	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
possibility	NULL
that	NULL
a	NULL
Dex-induced	NULL
gene	NULL
product	NULL
could	NULL
participate	NULL
in	NULL
blocking	NULL
transcriptional	NULL
induction	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

Among	NULL
the	NULL
genes	NULL
reported	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
glucocorticoids	NULL
,	NULL
the	NULL
requirement	NULL
for	NULL
a	NULL
newly	NULL
synthesized	NULL
protein	NULL
to	NULL
block	NULL
IL-2	NULL
induction	NULL
appeared	NULL
to	NULL
be	NULL
best	NULL
satisfied	NULL
by	NULL
GILZ	NULL
,	NULL
whose	NULL
leucine	NULL
zipper	NULL
is	NULL
characteristic	NULL
of	NULL
transcriptional	NULL
regulators	NULL
and	NULL
whose	NULL
expression	NULL
is	NULL
limited	NULL
to	NULL
lymphoid	NULL
cells	NULL
(	NULL
384	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
GILZ	NULL
inhibited	NULL
activation-induced	NULL
up-regulation	NULL
of	NULL
the	NULL
FasL	NULL
promoter	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
promoters	NULL
of	NULL
two	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
FasL	NULL
regulation	NULL
,	NULL
Egr-2	NULL
and	NULL
Egr-3	NULL
.	NULL

Up-regulation	NULL
of	NULL
Egr-2	NULL
and	NULL
Egr-3	NULL
requires	NULL
the	NULL
participation	NULL
of	NULL
NFAT	NULL
,	NULL
and	NULL
indeed	NULL
a	NULL
critical	NULL
NFAT	NULL
site	NULL
has	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
each	NULL
gene	NULL
(	NULL
38	NULL
,	NULL
39	NULL
)	NULL
.	NULL

With	NULL
rare	NULL
exceptions	NULL
,	NULL
NFAT	NULL
elements	NULL
are	NULL
composite	NULL
elements	NULL
that	NULL
contain	NULL
an	NULL
AP-1-binding	NULL
site	NULL
and	NULL
are	NULL
thus	NULL
more	NULL
accurately	NULL
termed	NULL
NFAT/AP-1	NULL
elements	NULL
(	NULL
51	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
GILZ	NULL
potently	NULL
inhibited	NULL
gene	NULL
expression	NULL
driven	NULL
by	NULL
an	NULL
AP-1-responsive	NULL
element	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
intact	NULL
IL-2	NULL
promoter	NULL
depends	NULL
on	NULL
the	NULL
proximal	NULL
TRE	NULL
(	NULL
57	NULL
)	NULL
,	NULL
thus	NULL
accounting	NULL
for	NULL
the	NULL
increased	NULL
inhibition	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
over	NULL
that	NULL
of	NULL
the	NULL
NFAT/AP-1	NULL
element	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
the	NULL
GILZ	NULL
leucine	NULL
zipper	NULL
does	NULL
not	NULL
interact	NULL
with	NULL
c-Fos	NULL
or	NULL
c-Jun	NULL
but	NULL
is	NULL
capable	NULL
of	NULL
mediating	NULL
homodimerization	NULL
implies	NULL
that	NULL
GILZ	NULL
can	NULL
form	NULL
a	NULL
homodimer	NULL
in	NULL
vivo	NULL
.	NULL

However	NULL
,	NULL
the	NULL
near-wild	NULL
type	NULL
repressive	NULL
activity	NULL
of	NULL
a	NULL
GILZ	NULL
mutant	NULL
lacking	NULL
the	NULL
leucine	NULL
zipper	NULL
suggests	NULL
that	NULL
GILZ	NULL
can	NULL
function	NULL
as	NULL
a	NULL
monomer	NULL
.	NULL

The	NULL
leucine	NULL
zipper	NULL
could	NULL
also	NULL
enable	NULL
dimerization	NULL
with	NULL
other	NULL
partners	NULL
,	NULL
such	NULL
as	NULL
the	NULL
closely	NULL
related	NULL
protein	NULL
TSC-22	NULL
,	NULL
which	NULL
also	NULL
has	NULL
a	NULL
leucine	NULL
zipper	NULL
and	NULL
can	NULL
bind	NULL
GILZ	NULL
in	NULL
vitro	NULL
.	NULL

°	NULL
P.	NULL
R.	NULL
Mittelstadt	NULL
and	NULL
J.	NULL
D.	NULL
Ashwell	NULL
,	NULL
unpublished	NULL
observations	NULL
.	NULL

29609	NULL
TSC-22	NULL
was	NULL
identified	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
up-regulation	NULL
of	NULL
its	NULL
mRNA	NULL
by	NULL
transforming	NULL
growth	NULL
factor-	NULL
,	NULL
can	NULL
also	NULL
be	NULL
induced	NULL
by	NULL
Dex	NULL
,	NULL
and	NULL
exhibited	NULL
transcriptional	NULL
repressive	NULL
activity	NULL
when	NULL
tethered	NULL
to	NULL
a	NULL
promoter	NULL
through	NULL
fusion	NULL
to	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
Gal4	NULL
protein	NULL
(	NULL
58	NULL
)	NULL
.	NULL

Although	NULL
homologous	NULL
to	NULL
and	NULL
capable	NULL
of	NULL
heterodimerization	NULL
with	NULL
GILZ	NULL
,	NULL
TSC-22	NULL
appears	NULL
to	NULL
have	NULL
distinct	NULL
biological	NULL
activities	NULL
.	NULL

For	NULL
example	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
in	NULL
Jurkat	NULL
cells	NULL
TSC-22	NULL
behaved	NULL
as	NULL
a	NULL
transcriptional	NULL
acti-vator	NULL
,	NULL
causing	NULL
a	NULL
3-	NULL
to	NULL
5-fold	NULL
increase	NULL
in	NULL
the	NULL
PMA	NULL
and	NULL
ionomy-cin-stimulated	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
reporter	NULL
when	NULL
transiently	NULL
expressed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
these	NULL
two	NULL
leucine	NULL
zipper-containing	NULL
proteins	NULL
can	NULL
modify	NULL
each	NULL
other	NULL
's	NULL
behavior	NULL
when	NULL
concomitantly	NULL
expressed	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
a	NULL
study	NULL
using	NULL
microarray	NULL
analysis	NULL
to	NULL
identify	NULL
developmentally	NULL
regulated	NULL
genes	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
GILZ	NULL
was	NULL
found	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
resting	NULL
B	NULL
cells	NULL
from	NULL
a	NULL
mouse	NULL
transgenic	NULL
for	NULL
a	NULL
HEL-specific	NULL
antigen	NULL
receptor	NULL
and	NULL
was	NULL
down-regulated	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
activated	NULL
with	NULL
antigen	NULL
(	NULL
59	NULL
)	NULL
.	NULL

Other	NULL
genes	NULL
encoding	NULL
known	NULL
transcriptional	NULL
repressors	NULL
,	NULL
such	NULL
as	NULL
Id3	NULL
,	NULL
LKLF	NULL
,	NULL
and	NULL
BKLF	NULL
,	NULL
were	NULL
also	NULL
down-regulated	NULL
in	NULL
the	NULL
activated	NULL
B	NULL
cells	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
view	NULL
that	NULL
GILZ	NULL
may	NULL
act	NULL
as	NULL
a	NULL
transcriptional	NULL
repressor	NULL
in	NULL
vivo	NULL
and	NULL
indicative	NULL
of	NULL
a	NULL
role	NULL
for	NULL
GILZ	NULL
outside	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
any	NULL
case	NULL
,	NULL
the	NULL
results	NULL
presented	NULL
in	NULL
this	NULL
report	NULL
indicate	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
possibly	NULL
causing	NULL
direct	NULL
interference	NULL
through	NULL
the	NULL
GR	NULL
,	NULL
in	NULL
T	NULL
cells	NULL
glucocorticoids	NULL
induce	NULL
at	NULL
least	NULL
one	NULL
molecule	NULL
(	NULL
GILZ	NULL
)	NULL
that	NULL
itself	NULL
can	NULL
bind	NULL
to	NULL
and	NULL
interfere	NULL
with	NULL
AP-1	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Nancy	NULL
Colburn	NULL
for	NULL
generously	NULL
providing	NULL
the	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
expression	NULL
vectors	NULL
and	NULL
Ralph	NULL
Kubo	NULL
for	NULL
the	NULL
monoclonal	NULL
antibody	NULL
against	NULL
TCR-£	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Boumpas	NULL
,	NULL
D.	NULL
T.	NULL
,	NULL
Chrousos	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Wilder	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Cupps	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
and	NULL
Balow	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Arn	NULL
.	NULL

Intern	NULL
.	NULL

Med	NULL
.	NULL

119	NULL
,	NULL
1198-1208	NULL
.	NULL

Gottlicher	NULL
,	NULL
M.	NULL
,	NULL
Heck	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Herrlich	NULL
,	NULL
P.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Med	NULL
.	NULL

76	NULL
,	NULL
480-489	NULL
.	NULL

Ashwell	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lu	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
and	NULL
Vacchio	NULL
,	NULL
M.	NULL
S.	NULL
(	NULL
2000	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

18	NULL
,	NULL
309-345	NULL
.	NULL

Crispe	NULL
,	NULL
I.	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Immunity	NULL
1	NULL
,	NULL
347-349	NULL
.	NULL

Yang	NULL
,	NULL
Y.	NULL
,	NULL
Mercep	NULL
,	NULL
M.	NULL
,	NULL
Ware	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
and	NULL
Ashwell	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181	NULL
,	NULL
1673-1682	NULL
6	NULL
.	NULL

Lu	NULL
,	NULL
W.	NULL
,	NULL
Salerno-Goncalves	NULL
,	NULL
R.	NULL
,	NULL
Yuan	NULL
,	NULL
J.	NULL
,	NULL
Sylvie	NULL
,	NULL
D.	NULL
,	NULL
Han	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
and	NULL
Andrieu	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
AIDS	NULL
9	NULL
,	NULL
35-42	NULL
.	NULL

Beato	NULL
,	NULL
M.	NULL
,	NULL
Herrlich	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Schutz	NULL
,	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
88	NULL
,	NULL
851-857	NULL
.	NULL

Onate	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Tsai	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
Tsai	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
O'Malley	NULL
,	NULL
B.	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
270	NULL
,	NULL
1354-1857	NULL
9	NULL
.	NULL

Chen	NULL
,	NULL
H.	NULL
,	NULL
Lin	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Schiltz	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Chakravarti	NULL
,	NULL
D.	NULL
,	NULL
Nash	NULL
,	NULL
A.	NULL
,	NULL
Nagy	NULL
,	NULL
L.	NULL
,	NULL
Privalsky	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Nakatani	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Cell	NULL
90	NULL
,	NULL
569-580	NULL
10	NULL
.	NULL

Blanco	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Minucci	NULL
,	NULL
S.	NULL
,	NULL
Lu	NULL
,	NULL
J.	NULL
,	NULL
Yang	NULL
,	NULL
X.	NULL
J.	NULL
,	NULL
Walker	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
Chen	NULL
,	NULL
H.	NULL
,	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Nakatani	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Ozato	NULL
,	NULL
K.	NULL
(	NULL
1998	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

12	NULL
,	NULL
1638-1651	NULL
11	NULL
.	NULL

Chandler	NULL
,	NULL
V.	NULL
L.	NULL
,	NULL
Maler	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Yamamoto	NULL
,	NULL
K.	NULL
R.	NULL
(	NULL
1983	NULL
)	NULL
Cell	NULL
33	NULL
,	NULL
489-499	NULL
12	NULL
.	NULL

Karin	NULL
,	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Cell	NULL
98	NULL
,	NULL
487-490	NULL
13	NULL
.	NULL

Zhang	NULL
,	NULL
G.	NULL
,	NULL
Zhang	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Duff	NULL
,	NULL
G.	NULL
W.	NULL
(	NULL
1997	NULL
)	NULL
DNA	NULL
Cell	NULL
Biol	NULL
.	NULL

16	NULL
,	NULL
145-152	NULL
14	NULL
.	NULL

Drouin	NULL
,	NULL
J.	NULL
,	NULL
Trifiro	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Plante	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
Nemer	NULL
,	NULL
M.	NULL
,	NULL
Eriksson	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Wrange	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
5805-5314	NULL
15	NULL
.	NULL

Sakai	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Helms	NULL
,	NULL
S.	NULL
,	NULL
Carlstedt-Duke	NULL
,	NULL
J.	NULL
,	NULL
Gustafsson	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Rottman	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
and	NULL
Yamamoto	NULL
,	NULL
K.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
1144-1154	NULL
16	NULL
.	NULL

Akerblom	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
Slater	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Beato	NULL
,	NULL
M.	NULL
,	NULL
Baxter	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Mellon	NULL
,	NULL
P.	NULL
L.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
350-353	NULL
17	NULL
.	NULL

Mordacq	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
and	NULL
Linzer	NULL
,	NULL
D.	NULL
I	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

8	NULL
,	NULL
760-769	NULL
18	NULL
.	NULL

Diamond	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Miner	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Yoshinaga	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
and	NULL
Yamamoto	NULL
,	NULL
K.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
249	NULL
,	NULL
1266-1272	NULL
19	NULL
.	NULL

Ponta	NULL
,	NULL
H.	NULL
,	NULL
Cato	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
and	NULL
Herrlich	NULL
,	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1129	NULL
,	NULL
255-261	NULL
20	NULL
.	NULL

Jonat	NULL
,	NULL
C.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Park	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
Cato	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Gebel	NULL
,	NULL
S.	NULL
,	NULL
Ponta	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Herrlich	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1189-1204	NULL
21	NULL
.	NULL

Yang-Yen	NULL
,	NULL
H.	NULL
F.	NULL
,	NULL
Chambard	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Sun	NULL
,	NULL
Y.	NULL
L.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
Schmidt	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Drouin	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1205-1215	NULL
22	NULL
.	NULL

Konig	NULL
,	NULL
H.	NULL
,	NULL
Ponta	NULL
,	NULL
H.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
and	NULL
Herrlich	NULL
,	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
2241-2246	NULL
28	NULL
.	NULL

Schule	NULL
,	NULL
R.	NULL
,	NULL
Rangarajan	NULL
,	NULL
P.	NULL
,	NULL
Kliewer	NULL
,	NULL
S.	NULL
,	NULL
Ransone	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Bolado	NULL
,	NULL
J.	NULL
,	NULL
Yang	NULL
,	NULL
N.	NULL
,	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1217-1226	NULL
24	NULL
.	NULL

Ray	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Prefontaine	NULL
,	NULL
K.	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
752-1756	NULL
25	NULL
.	NULL

Kutoh	NULL
,	NULL
E.	NULL
,	NULL
Stromstedt	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
and	NULL
Poellinger	NULL
,	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
4960-4969	NULL
26	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Yang	NULL
,	NULL
M.	NULL
X	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
4971-4979	NULL
27	NULL
.	NULL

Heck	NULL
,	NULL
S.	NULL
,	NULL
Kullmann	NULL
,	NULL
M.	NULL
,	NULL
Gast	NULL
,	NULL
A.	NULL
,	NULL
Ponta	NULL
,	NULL
H.	NULL
,	NULL
Rabmsdorf	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Herrlich	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Cato	NULL
,	NULL
A.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

13	NULL
,	NULL
4087-4095	NULL
28	NULL
.	NULL

Reichardt	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Kaestner	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
Tuckermann	NULL
,	NULL
J.	NULL
,	NULL
Kretz	NULL
,	NULL
O.	NULL
,	NULL
Wessely	NULL
,	NULL
O.	NULL
,	NULL
Bock	NULL
,	NULL
R.	NULL
,	NULL
Gass	NULL
,	NULL
P.	NULL
,	NULL
Schmid	NULL
,	NULL
W.	NULL
,	NULL
Herrlich	NULL
,	NULL
P.	NULL
,	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Schutz	NULL
,	NULL
G.	NULL
(	NULL
1998	NULL
)	NULL
Cell	NULL
98	NULL
,	NULL
581-541	NULL
29	NULL
.	NULL

Klein-Hitpass	NULL
,	NULL
L.	NULL
,	NULL
Schwerk	NULL
,	NULL
C.	NULL
,	NULL
Kahmann	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Vassen	NULL
,	NULL
L.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

to	NULL
bo	NULL
gigs	NULL
go	NULL
~	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
29610	NULL
30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

Med	NULL
.	NULL

76	NULL
,	NULL
490-496	NULL
Kamei	NULL
,	NULL
Y.	NULL
,	NULL
Xu	NULL
,	NULL
L.	NULL
,	NULL
Heinzel	NULL
,	NULL
T.	NULL
,	NULL
Torchia	NULL
,	NULL
J.	NULL
,	NULL
Kurokawa	NULL
,	NULL
R.	NULL
,	NULL
Gloss	NULL
,	NULL
B.	NULL
,	NULL
Lin	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Heyman	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Rose	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Glass	NULL
,	NULL
C.	NULL
K.	NULL
,	NULL
and	NULL
Rosenfeld	NULL
,	NULL
M.	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
85	NULL
,	NULL
403-414	NULL
Collingwood	NULL
,	NULL
T.	NULL
N.	NULL
,	NULL
Urnov	NULL
,	NULL
F.	NULL
D.	NULL
,	NULL
and	NULL
Wolffe	NULL
,	NULL
A.	NULL
P.	NULL
(	NULL
1999	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

28	NULL
,	NULL
255-275	NULL
De	NULL
Bosscher	NULL
,	NULL
K.	NULL
,	NULL
Schmitz	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Vanden	NULL
Berghe	NULL
,	NULL
W.	NULL
,	NULL
Plaisance	NULL
,	NULL
S.	NULL
,	NULL
Fiers	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Haegeman	NULL
,	NULL
G.	NULL
(	NULL
1997	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

94	NULL
,	NULL
13504-13509	NULL
Sillard	NULL
,	NULL
R.	NULL
,	NULL
Schulz-Knappe	NULL
,	NULL
P.	NULL
,	NULL
Vogel	NULL
,	NULL
P.	NULL
,	NULL
Raida	NULL
,	NULL
M.	NULL
,	NULL
Bensch	NULL
,	NULL
K.	NULL
W.	NULL
,	NULL
Forssmann	NULL
,	NULL
W.	NULL
G.	NULL
,	NULL
and	NULL
Mutt	NULL
,	NULL
V.	NULL
(	NULL
1993	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

216	NULL
,	NULL
429-436	NULL
D'Adamio	NULL
,	NULL
F.	NULL
,	NULL
Zollo	NULL
,	NULL
O.	NULL
,	NULL
Moraca	NULL
,	NULL
R.	NULL
,	NULL
Ayroldi	NULL
,	NULL
E.	NULL
,	NULL
Bruscoli	NULL
,	NULL
S.	NULL
,	NULL
Bartoli	NULL
,	NULL
A.	NULL
,	NULL
Cannarile	NULL
,	NULL
L.	NULL
,	NULL
Migliorati	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Riccardi	NULL
,	NULL
C.	NULL
(	NULL
1997	NULL
)	NULL
Immunity	NULL
7	NULL
,	NULL
808-812	NULL
Sussman	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Bonifacino	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Lippincott-Schwartz	NULL
,	NULL
J.	NULL
,	NULL
Weissman	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Saito	NULL
,	NULL
T.	NULL
,	NULL
Klausner	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
and	NULL
Ashwell	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
52	NULL
,	NULL
85-95	NULL
Ono	NULL
,	NULL
S.	NULL
,	NULL
Ohno	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Saito	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Immunity	NULL
2	NULL
,	NULL
689-644	NULL
Mittelstadt	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
Ashwell	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
8744-3751	NULL
Rengarajan	NULL
,	NULL
J.	NULL
,	NULL
Mittelstadt	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
Mages	NULL
,	NULL
H.	NULL
W.	NULL
,	NULL
Gerth	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Kroczek	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Ashwell	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
2000	NULL
)	NULL
Immunity	NULL
12	NULL
,	NULL
2983-300	NULL
Mages	NULL
,	NULL
H.	NULL
W.	NULL
,	NULL
Baag	NULL
,	NULL
R.	NULL
,	NULL
Steiner	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Kroczek	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
7157-7165	NULL
Petrak	NULL
,	NULL
D.	NULL
,	NULL
Memon	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Birrer	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Ashwell	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Zacharchuk	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
2046-2051	NULL
Hedrick	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Matis	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Hecht	NULL
,	NULL
T.	NULL
T.	NULL
,	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
Longo	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Heber-Katz	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Schwartz	NULL
,	NULL
R.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
141-152	NULL
Gillis	NULL
,	NULL
S.	NULL
,	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Smith	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

128	NULL
,	NULL
1624-1631	NULL
Vacca	NULL
,	NULL
A.	NULL
,	NULL
Martinotti	NULL
,	NULL
S.	NULL
,	NULL
Screpanti	NULL
,	NULL
I.	NULL
,	NULL
Maroder	NULL
,	NULL
M.	NULL
,	NULL
Felli	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Farina	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Gismondi	NULL
,	NULL
A.	NULL
,	NULL
Santoni	NULL
,	NULL
A.	NULL
,	NULL
Frati	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Gulino	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
8075-8080	NULL
Kronke	NULL
,	NULL
M.	NULL
,	NULL
Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Depper	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1985	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

Inhibition	NULL
of	NULL
AP-1	NULL
by	NULL
GILZ	NULL
Med	NULL
.	NULL

161	NULL
,	NULL
1593-1598	NULL
Lau	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
(	NULL
1985	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

4	NULL
,	NULL
8145-3151	NULL
Nakamura	NULL
,	NULL
H.	NULL
,	NULL
Haley	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Nakamura	NULL
,	NULL
T.	NULL
,	NULL
Luster	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
and	NULL
Lilly	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

275	NULL
,	NULL
L6O1-L610	NULL
Li-Weber	NULL
,	NULL
M.	NULL
,	NULL
Laur	NULL
,	NULL
O.	NULL
,	NULL
and	NULL
Krammer	NULL
,	NULL
P.	NULL
H.	NULL
(	NULL
1999	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

29	NULL
,	NULL
3017-3027	NULL
Latinis	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Norian	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Eliason	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
Koretzky	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
81427-81484	NULL
Holtz-Heppelmann	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Algeciras	NULL
,	NULL
A.	NULL
,	NULL
Badley	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
and	NULL
Paya	NULL
,	NULL
C.	NULL
V.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
4416-4423	NULL
Matsui	NULL
,	NULL
K.	NULL
,	NULL
Fine	NULL
,	NULL
A.	NULL
,	NULL
Zhu	NULL
,	NULL
B.	NULL
,	NULL
Marshak-Rothstein	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Ju	NULL
,	NULL
S.	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

161	NULL
,	NULL
3469-3473	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
Luo	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
(	NULL
1997	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

15	NULL
,	NULL
707-747	NULL
Chen	NULL
,	NULL
L.	NULL
,	NULL
Glover	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Harrison	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1998	NULL
)	NULL
Nature	NULL
392	NULL
,	NULL
42-48	NULL
Kang	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Beverly	NULL
,	NULL
B.	NULL
,	NULL
Tran	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Brorson	NULL
,	NULL
K.	NULL
,	NULL
Schwartz	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
and	NULL
Lenardo	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Science	NULL
257	NULL
,	NULL
1184-1188	NULL
Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Mattila	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175	NULL
,	NULL
1235-1245	NULL
Shan	NULL
,	NULL
X.	NULL
,	NULL
Czar	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Bunnell	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Liu	NULL
,	NULL
P.	NULL
,	NULL
Liu	NULL
,	NULL
Y.	NULL
,	NULL
Schwartzberg	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
and	NULL
.	NULL

Wange	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
2000	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

20	NULL
,	NULL
6945-6957	NULL
Wright	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
Carlstedt-Duke	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Gustafsson	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
14763-14769	NULL
Serfling	NULL
,	NULL
E.	NULL
,	NULL
Berberich-Siebelt	NULL
,	NULL
F.	NULL
,	NULL
Chuypilo	NULL
,	NULL
S.	NULL
,	NULL
Jankevics	NULL
,	NULL
E.	NULL
,	NULL
Klein-Hessling	NULL
,	NULL
S.	NULL
,	NULL
Twardzik	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Avots	NULL
,	NULL
A	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1498	NULL
,	NULL
1-18	NULL
Kester	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
Blanchetot	NULL
,	NULL
C.	NULL
,	NULL
den	NULL
Hertog	NULL
,	NULL
J.	NULL
,	NULL
van	NULL
der	NULL
Saag	NULL
,	NULL
P.	NULL
T.	NULL
,	NULL
and	NULL
van	NULL
der	NULL
Burg	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274	NULL
,	NULL
27489-27447	NULL
Glynne	NULL
,	NULL
R.	NULL
,	NULL
Akkaraju	NULL
,	NULL
S.	NULL
,	NULL
Healy	NULL
,	NULL
J.	NULL
I.	NULL
,	NULL
Rayner	NULL
,	NULL
J.	NULL
,	NULL
Goodnow	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
and	NULL
Mack	NULL
,	NULL
D.	NULL
H.	NULL
(	NULL
2000	NULL
)	NULL
Nature	NULL
408	NULL
,	NULL
672-676	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Inhibition	NULL
of	NULL
AP-1	NULL
by	NULL
the	NULL
Glucocorticoid-inducible	NULL
Protein	NULL
GILZ	NULL
Paul	NULL
R.	NULL
Mittelstadt	NULL
and	NULL
Jonathan	NULL
D.	NULL
Ashwell	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

2001	NULL
,	NULL
276:29603-29610.	NULL
doi	NULL
:	NULL
10.1074/jbc.M101522200	NULL
originally	NULL
published	NULL
online	NULL
June	NULL
7	NULL
,	NULL
2001	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
doi	NULL
:	NULL
10.1074/jbe.M101522200	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
59	NULL
references	NULL
,	NULL
27	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL

